Journal Home > Volume 17 , Issue 2
Nano Research 2024, 17(2): 691-714 https://doi.org/10.1007/s12274-023-6283-9
Review Article | Issue | Published: 07 December 2023

Bioinspired nanomaterials for the treatment of bacterial infections

Show Author's Information Xiaojing Ma,§,  Wenjing Tang,§,  Rong Yang( )
Robert F. Smith School of Chemical & Biomolecular Engineering, Cornell University, Ithaca, NY 14853, USA

§ Xiaojing Ma and Wenjing Tang contributed equally to this work.

Keywords:
bacteria, antimicrobial, nanozyme, liposome, infectious disease, bioinspired nanomaterial
Topics:
AntibioticsAntibodies Drug deliveryEnzymesNanoparticles
Cite this article:
Ma X, Tang W, Yang R. Bioinspired nanomaterials for the treatment of bacterial infections. Nano Research, 2024, 17(2): 691-714. https://doi.org/10.1007/s12274-023-6283-9
Download citation
EndNote(RIS)
BibTeX

493

Views

49

Downloads

Citations

2

Crossref

1

WoS

2

Scopus

0

CSCD

Abstract Full text About this article

Infectious diseases pose a serious threat to global health. Although immunizations can control most viral infections, bacterial infections, particularly those caused by drug-resistant strains, continue to cause high rates of illness and death. Unfortunately, the creation of new antibiotics has come to a grinding halt in the last ten years. In response to this crisis, nanotechnology has emerged as a hopeful solution to tackle drug resistance and enhance treatment results. A large variety of biomimetic nanomaterials, termed nanozymes, have demonstrated strong antimicrobial efficacy. While the inherent toxicity of nanomaterials is a concern, recent studies have harnessed the stimuli-responsiveness of nanomaterials to enable local and/or targeted delivery to reduce the treatment side effects. Indeed, the physicochemical versatility of nanomaterials affords many degrees of freedom that enable rational design of smart or autonomous therapeutics, which cannot be achieved using conventional antibiotics. The design straddles the fields of catalysis, nanoscience, microbiology, and translational medicine. To provide an overview of this interdisciplinary landscape, this review is organized based on composition into lipid, metal, metal oxide, and non-metallic nanomaterials. Liposomes as a delivery vehicle enhance bioavailability and reduce toxicity. Metal- and metal oxide-based nanomaterials inhibit bacterial growth by mimicking natural enzymatic activities such as peroxidase (POD) and oxidase. Furthermore, carbon-, polymer-, and cell membrane-based nanomaterials are combined into a discussion on non-metallic materials. At the end of this review, potentially fruitful directions for future bioinspired nanomaterials in infectious disease treatment are included.


menu
Abstract
Full text
Outline
About this article

Bioinspired nanomaterials for the treatment of bacterial infections

Show Author's information Xiaojing Ma,§, Wenjing Tang,§, Rong Yang( )
Robert F. Smith School of Chemical & Biomolecular Engineering, Cornell University, Ithaca, NY 14853, USA

§ Xiaojing Ma and Wenjing Tang contributed equally to this work.

Abstract

Infectious diseases pose a serious threat to global health. Although immunizations can control most viral infections, bacterial infections, particularly those caused by drug-resistant strains, continue to cause high rates of illness and death. Unfortunately, the creation of new antibiotics has come to a grinding halt in the last ten years. In response to this crisis, nanotechnology has emerged as a hopeful solution to tackle drug resistance and enhance treatment results. A large variety of biomimetic nanomaterials, termed nanozymes, have demonstrated strong antimicrobial efficacy. While the inherent toxicity of nanomaterials is a concern, recent studies have harnessed the stimuli-responsiveness of nanomaterials to enable local and/or targeted delivery to reduce the treatment side effects. Indeed, the physicochemical versatility of nanomaterials affords many degrees of freedom that enable rational design of smart or autonomous therapeutics, which cannot be achieved using conventional antibiotics. The design straddles the fields of catalysis, nanoscience, microbiology, and translational medicine. To provide an overview of this interdisciplinary landscape, this review is organized based on composition into lipid, metal, metal oxide, and non-metallic nanomaterials. Liposomes as a delivery vehicle enhance bioavailability and reduce toxicity. Metal- and metal oxide-based nanomaterials inhibit bacterial growth by mimicking natural enzymatic activities such as peroxidase (POD) and oxidase. Furthermore, carbon-, polymer-, and cell membrane-based nanomaterials are combined into a discussion on non-metallic materials. At the end of this review, potentially fruitful directions for future bioinspired nanomaterials in infectious disease treatment are included.

Keywords: bacteria, antimicrobial, nanozyme, liposome, infectious disease, bioinspired nanomaterial

References(342)

[1]

Carvalho, G. C.; Sábio, R. M.; de Cássia Ribeiro, T.; Monteiro, A. S.; Pereira, D. V.; Ribeiro, S. J. L.; Chorilli, M. Highlights in mesoporous silica nanoparticles as a multifunctional controlled drug delivery nanoplatform for infectious diseases treatment. Pharm. Res. 2020, 37, 191.
DOI Google Scholar
[2]

Chen, P. Y.; Lang, J. Y.; Zhou, Y. L.; Khlyustova, A.; Zhang, Z. Y.; Ma, X. J.; Liu, S.; Cheng, Y. F.; Yang, R. An imidazolium-based zwitterionic polymer for antiviral and antibacterial dual functional coatings. Sci. Adv. 2022, 8, eabl8812.
DOI Google Scholar
[3]

GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2022, 400, 2221–2248.
DOI Google Scholar
[4]

Quagliarello, V.; Scheld, W. M. Bacterial meningitis: Pathogenesis, pathophysiology, and progress. N. Engl. J. Med. 1992, 327, 864–872.
DOI Google Scholar
[5]

Tzeng, Y. L.; Stephens, D. S. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect. 2000, 2, 687–700.
DOI Google Scholar
[6]

van Hal, S. J.; Jensen, S. O.; Vaska, V. L.; Espedido, B. A.; Paterson, D. L.; Gosbell, I. B. Predictors of mortality in Staphylococcus aureus bacteremia. Clin. Microbiol. Rev. 2012, 25, 362–386.
DOI Google Scholar
[7]
Tang, Y. W.; Sussman, M.; Liu, D. Y.; Poxton, I.; Schwartzman, J. Molecular Medical Microbiology; 2nd edition. Academic Press, 2014.
DOI
[8]

Deurenberg, R. H.; Vink, C.; Kalenic, S.; Friedrich, A. W.; Bruggeman, C. A.; Stobberingh, E. E. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 2007, 13, 222–235.
DOI Google Scholar
[9]

Aminov, R. I. A brief history of the antibiotic era: Lessons learned and challenges for the future. Front. Microbiol. 2010, 1, 134.
DOI Google Scholar
[10]

Coates, A. R. M.; Halls, G.; Hu, Y. M. Novel classes of antibiotics or more of the same. Br. J. Pharmacol. 2011, 163, 184–194.
DOI Google Scholar
[11]

Hashemi, S.; Nasrollah, A.; Rajabi, M. Irrational antibiotic prescribing: A local issue or global concern. EXCLI J. 2013, 12, 384–395.
Google Scholar
[12]

Zeng, X. M.; Lin, J. Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria. Front. Microbiol. 2013, 4, 128.
DOI Google Scholar
[13]

Velkov, T.; Thompson, P. E.; Nation, R. L.; Li, J. Structure–activity relationships of polymyxin antibiotics. J. Med. Chem. 2010, 53, 1898–1916.
DOI Google Scholar
[14]

Krause, K. M.; Serio, A. W.; Kane, T. R.; Connolly, L. E. Aminoglycosides: An overview. Cold Spring Harb. Perspect. Med. 2016, 6, a027029.
DOI Google Scholar
[15]

Champney, W. S. Antibiotics targeting bacterial ribosomal subunit biogenesis. J. Antimicrob. Chemother. 2020, 75, 787–806.
DOI Google Scholar
[16]

Schwarz, S.; Shen, J. Z.; Kadlec, K.; Wang, Y.; Michael, G. B.; Feßler, A. T.; Vester, B. Lincosamides, streptogramins, phenicols, and pleuromutilins: Mode of action and mechanisms of resistance. Cold Spring Harb. Perspect. Med. 2016, 6, a027037.
DOI Google Scholar
[17]

Bush, N. G.; Diez-Santos, I.; Abbott, L. R.; Maxwell, A. Quinolones: Mechanism, lethality and their contributions to antibiotic resistance. Molecules 2020, 25, 5662.
DOI Google Scholar
[18]

Ausubel, J. H.; Meyer, P. S.; Wernick, I. K. Death and the human environment: The United States in the 20th century. Technol. Soc. 2001, 23, 131–146.
DOI Google Scholar
[19]

Casal, M.; Vaquero, M.; Rinder, H.; Tortoli, E.; Grosset, J.; Rüsch-Gerdes, S.; Gutiérrez, J.; Jarlier, V. A case-control study for multidrug-resistant tuberculosis: Risk factors in four European countries. Microb. Drug Resist. 2005, 11, 62–67.
DOI Google Scholar
[20]

Chambers, H. F. The changing epidemiology of Staphylococcus aureus. Emerg. Infect. Dis. 2001, 7, 178–182.
DOI Google Scholar
[21]

Hemaiswarya, S.; Kruthiventi, A. K.; Doble, M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 2008, 15, 639–652.
DOI Google Scholar
[22]

Uldum, S. A.; Bangsborg, J. M.; Gahrn-Hansen, B.; Ljung, R.; Mølvadgaard, M.; Petersen, R. F.; Svarrer, C. W. Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Eurosurveillance 2012, 17, 20073.
DOI Google Scholar
[23]

Livermore, D. M. Bacterial resistance: Origins, epidemiology, and impact. Clin. Infect. Dis. 2003, 36, S11–S23.
DOI Google Scholar
[24]

Van Bambeke, F.; Glupczynski, Y.; Plésiat, P.; Pechère, J. C.; Tulkens, P. M. Antibiotic efflux pumps in prokaryotic cells: Occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J. Antimicrob. Chemother. 2003, 51, 1055–1065.
DOI Google Scholar
[25]

Berger-Bächi, B. Resistance mechanisms of Gram-positive bacteria. Int. J. Med. Microbiol. 2002, 292, 27–35.
DOI Google Scholar
[26]

Xu, Z.; Li, L.; Shirtliff, M. E.; Peters, B. M.; Li, B.; Peng, Y.; Alam, M. J.; Yamasaki, S.; Shi, L. Resistance class 1 integron in clinical methicillin-resistant Staphylococcus aureus strains in southern China, 2001-2006. Clin. Microbiol. Infect. 2011, 17, 714–718.
DOI Google Scholar
[27]

Levy, S. B. Antibiotic resistance: Consequences of inaction. Clin. Infect. Dis. 2001, 33, S124–S129.
DOI Google Scholar
[28]

Dancer, S. J. The problem with cephalosporins. J. Antimicrob. Chemother. 2001, 48, 463–478.
DOI Google Scholar
[29]

Capita, R.; Alonso-Calleja, C. Antibiotic-resistant bacteria: A challenge for the food industry. Crit. Rev. Food Sci. Nutr. 2013, 53, 11–48.
DOI Google Scholar
[30]

Angsantikul, P.; Thamphiwatana, S.; Zhang, Q. Z.; Spiekermann, K.; Zhuang, J.; Fang, R. H.; Gao, W. W.; Obonyo, M.; Zhang, L. F. Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection. Adv. Ther. 2018, 1, 1800016.
DOI Google Scholar
[31]

Vickers, N. J. Animal communication: When I’m calling you, will you answer too. Curr. Biol. 2017, 27, R713–R715.
DOI Google Scholar
[32]

Gareev, K. G.; Grouzdev, D. S.; Koziaeva, V. V.; Sitkov, N. O.; Gao, H. L.; Zimina, T. M.; Shevtsov, M. Biomimetic nanomaterials: Diversity, technology, and biomedical applications. Nanomaterials 2022, 12, 2485.
DOI Google Scholar
[33]
Ngo, T. D. Biomimetic Technologies: Principles and Applications; Woodhead Publishing: Cambridge, 2015.
[34]

Zaidi, S. A. Molecular imprinted polymers as drug delivery vehicles. Drug Deliv. 2016, 23, 2262–2271.
DOI Google Scholar
[35]
Milovanovic, M.; Arsenijevic, A.; Milovanovic, J.; Kanjevac, T.; Arsenijevic, N. Nanoparticles in antiviral therapy. In Antimicrobial Nanoarchitectonics: From Synthesis to Applications. Grumezescu, A. M., Ed.; Elsevier: Amsterdam, 2017; pp 383–410.
DOI
[36]

Singh, L.; Kruger, H. G.; Maguire, G. E. M.; Govender, T.; Parboosing, R. The role of nanotechnology in the treatment of viral infections. Ther. Adv. Infect. Dis. 2017, 4, 105–131.
DOI Google Scholar
[37]

Evans, G. B.; Tyler, P. C.; Schramm, V. L. Immucillins in infectious diseases. ACS Infect. Dis. 2018, 4, 107–117.
DOI Google Scholar
[38]
Gupta, A.; Landis, R. F.; Rotello, V. M. Nanoparticle-based antimicrobials: Surface functionality is critical. F1000Res. 2016 , 5, 364.
DOI
[39]

Gupta, A.; Mumtaz, S.; Li, C. H.; Hussain, I.; Rotello, V. M. Combatting antibiotic-resistant bacteria using nanomaterials. Chem. Soc. Rev. 2019, 48, 415–427.
DOI Google Scholar
[40]

Pelgrift, R. Y.; Friedman, A. J. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Deliv. Rev. 2013, 65, 1803–1815.
DOI Google Scholar
[41]

Friedman, A.; Blecher, K.; Sanchez, D.; Tuckman-Vernon, C.; Gialanella, P.; Friedman, J. M.; Martinez, L. R.; Nosanchuk, J. D. Susceptibility of Gram-positive and negative bacteria to novel nitric oxide-releasing nanoparticle technology. Virulence 2011, 2, 217–221.
DOI Google Scholar
[42]

Hajipour, M. J.; Fromm, K. M.; Ashkarran, A. A.; de Aberasturi, D. J.; de Larramendi, I. R.; Rojo, T.; Serpooshan, V.; Parak, W. J.; Mahmoudi, M. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012, 30, 499–511.
DOI Google Scholar
[43]

Schairer, D. O.; Chouake, J. S.; Nosanchuk, J. D.; Friedman, A. J. The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence 2012, 3, 271–279.
DOI Google Scholar
[44]

Gupta, A.; Saleh, N. M.; Das, R.; Landis, R. F.; Bigdeli, A.; Motamedchaboki, K.; Campos, A. R.; Pomeroy, K.; Mahmoudi, M.; Rotello, V. M. Synergistic antimicrobial therapy using nanoparticles and antibiotics for the treatment of multidrug-resistant bacterial infection. Nano Futures 2017, 1, 015004.
DOI Google Scholar
[45]

Padwal, P.; Bandyopadhyaya, R.; Mehra, S. Polyacrylic acid-coated iron oxide nanoparticles for targeting drug resistance in mycobacteria. Langmuir 2014, 30, 15266–15276.
DOI Google Scholar
[46]

Nallathamby, P. D.; Lee, K. J.; Desai, T.; Xu, X. H. N. Study of the multidrug membrane transporter of single living Pseudomonas aeruginosa cells using size-dependent plasmonic nanoparticle optical probes. Biochemistry 2010, 49, 5942–5953.
DOI Google Scholar
[47]

Lang, J. Y.; Ma, X. J.; Liu, S. S.; Streever, D. L.; Serota, M. D.; Franklin, T.; Loew, E. R.; Yang, R. On-demand synthesis of antiseptics at the site of infection for treatment of otitis media. Nano Today 2022, 47, 101672.
DOI Google Scholar
[48]

Zhou, L. Y.; Qiu, T.; Lv, F. T.; Liu, L. B.; Ying, J. M.; Wang, S. Self-assembled nanomedicines for anticancer and antibacterial applications. Adv. Healthc. Mater. 2018, 7, 1800670.
DOI Google Scholar
[49]

Ma, X. J.; Lang, J. Y.; Chen, P. Y.; Yang, R. Silver nanoparticles as an effective antimicrobial against otitis media pathogens. AIChE J. 2021, 67, e17468.
DOI Google Scholar
[50]

Ma, X. J.; Lang, J. Y.; Chen, P. Y.; Tang, W. J.; Shindler, S.; Yang, R. A cascade nanozyme with antimicrobial effects against nontypeable Haemophilus influenzae. Nanoscale 2023, 15, 1014–1023.
DOI Google Scholar
[51]

Moretton, M. A.; Glisoni, R. J.; Chiappetta, D. A.; Sosnik, A. Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles. Colloids Surf. B: Biointerfaces 2010, 79, 467–479.
DOI Google Scholar
[52]

Vernekar, A. A.; Sinha, D.; Srivastava, S.; Paramasivam, P. U.; D’Silva, P.; Mugesh, G. An antioxidant nanozyme that uncovers the cytoprotective potential of vanadia nanowires. Nat. Commun. 2014, 5, 5301.
DOI Google Scholar
[53]

Kumar, M.; Curtis, A.; Hoskins, C. Application of nanoparticle technologies in the combat against anti-microbial resistance. Pharmaceutics 2018, 10, 11.
DOI Google Scholar
[54]

Luo, D. D.; Carter, K. A.; Molins, E. A. G.; Straubinger, N. L.; Geng, J. M.; Shao, S.; Jusko, W. J.; Straubinger, R. M.; Lovell, J. F. Pharmacokinetics and pharmacodynamics of liposomal chemophototherapy with short drug–light intervals. J. Control. Release  2019, 297, 39–47.
DOI Google Scholar
[55]

Rukavina, Z.; Vanić, Ž. Current trends in development of liposomes for targeting bacterial biofilms. Pharmaceutics 2016, 8, 18.
DOI Google Scholar
[56]

Ferreira, M.; Ogren, M.; Dias, J. N. R.; Silva, M.; Gil, S.; Tavares, L.; Aires-da-Silva, F.; Gaspar, M. M.; Aguiar, S. I. Liposomes as antibiotic delivery systems: A promising nanotechnological strategy against antimicrobial resistance. Molecules 2021, 26, 2047.
DOI Google Scholar
[57]

Gbian, D. L.; Omri, A. The impact of an efflux pump inhibitor on the activity of free and liposomal antibiotics against Pseudomonas aeruginosa. Pharmaceutics 2021, 13, 577.
DOI Google Scholar
[58]

Shang, Y. X.; Liu, F. S.; Wang, Y. N.; Li, N.; Ding, B. Q. Enzyme mimic nanomaterials and their biomedical applications. ChemBioChem 2020, 21, 2408–2418.
DOI Google Scholar
[59]

Yang, D. Z.; Chen, Z. Z.; Gao, Z.; Tammina, S. K.; Yang, Y. L. Nanozymes used for antimicrobials and their applications. Colloids Surf. B: Biointerfaces 2020, 195, 111252.
DOI Google Scholar
[60]

Chen, Z. W.; Wang, Z. Z.; Ren, J. S.; Qu, X. G. Enzyme mimicry for combating bacteria and biofilms. Acc. Chem. Res. 2018, 51, 789–799.
DOI Google Scholar
[61]

Ji, H. W.; Dong, K.; Yan, Z. Q.; Ding, C.; Chen, Z. W.; Ren, J. S.; Qu, X. G. Bacterial hyaluronidase self-triggered prodrug release for chemo-photothermal synergistic treatment of bacterial infection. Small 2016, 12, 6200–6206.
DOI Google Scholar
[62]

Yan, L.; Mu, J.; Ma, P. X.; Li, Q.; Yin, P. X.; Liu, X.; Cai, Y. Y.; Yu, H. P.; Liu, J. C.; Wang, G. Q. et al. Gold nanoplates with superb photothermal efficiency and peroxidase-like activity for rapid and synergistic antibacterial therapy. Chem. Commun. 2021, 57, 1133–1136.
DOI Google Scholar
[63]

Juven, B. J.; Pierson, M. D. Antibacterial effects of hydrogen peroxide and methods for its detection and quantitation. J. Food Prot. 1996, 59, 1233–1241.
DOI Google Scholar
[64]

Sies, H.; Berndt, C.; Jones, D. P. Oxidative stress. Annu. Rev. Biochem. 2017, 86, 715–748.
DOI Google Scholar
[65]

Wu, J. J. X.; Wang, X. Y.; Wang, Q.; Lou, Z. P.; Li, S. R.; Zhu, Y. Y.; Qin, L.; Wei, H. Nanomaterials with enzyme-like characteristics (nanozymes): Next-generation artificial enzymes (II). Chem. Soc. Rev. 2019, 48, 1004–1076.
DOI Google Scholar
[66]
Lin, S. C.; Wu, J. J. X.; Yao, J.; Cao, W.; Muhammad, F.; Wei, H. Nanozymes for biomedical sensing applications: From in vitro to living systems. In Biomedical Applications of Functionalized Nanomaterials. Sarmento, B.; das Neves, J., Eds.; Elsevier: Amsterdam, 2018; pp 171–209.
DOI
[67]

Ergene, C.; Yasuhara, K.; Palermo, E. F. Biomimetic antimicrobial polymers: Recent advances in molecular design. Polym. Chem. 2018, 9, 2407–2427.
DOI Google Scholar
[68]

Hu, C. M. J.; Zhang, L.; Aryal, S.; Cheung, C.; Fang, R. H.; Zhang, L. F. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl. Acad. Sci. USA 2011, 108, 10980–10985.
DOI Google Scholar
[69]

Kroll, A. V.; Fang, R. H.; Zhang, L. F. Biointerfacing and applications of cell membrane-coated nanoparticles. Bioconjug. Chem. 2017, 28, 23–32.
DOI Google Scholar
[70]

Dehaini, D.; Wei, X. L.; Fang, R. H.; Masson, S.; Angsantikul, P.; Luk, B. T.; Zhang, Y.; Ying, M.; Jiang, Y.; Kroll, A. V. et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv. Mater. 2017, 29, 1606209.
DOI Google Scholar
[71]

Oroojalian, F.; Beygi, M.; Baradaran, B.; Mokhtarzadeh, A.; Shahbazi, M. A. Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy. Small 2021, 17, 2006484.
DOI Google Scholar
[72]

Fang, R. H.; Hu, C. M. J.; Luk, B. T.; Gao, W. W.; Copp, J. A.; Tai, Y. Y.; O’Connor, D. E.; Zhang, L. F. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014, 14, 2181–2188.
DOI Google Scholar
[73]

Gootz, T. D. The global problem of antibiotic resistance. Crit. Rev. Immunol. 2010, 30, 79–93.
DOI Google Scholar
[74]

Hasan, T. H.; Al-Harmoosh, R. A. Mechanisms of antibiotics resistance in bacteria. Syst. Rev. Pharm. 2020, 11, 817–823.
Google Scholar
[75]

Andersson, D. I. Persistence of antibiotic resistant bacteria. Curr. Opin. Microbiol. 2003, 6, 452–456.
DOI Google Scholar
[76]

Singh, R.; Lillard, J. W. Jr. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 2009, 86, 215–223.
DOI Google Scholar
[77]

Kukowska-Latallo, J. F.; Candido, K. A.; Cao, Z. Y.; Nigavekar, S. S.; Majoros, I. J.; Thomas, T. P.; Balogh, L. P.; Khan, M. K.; Baker, J. R. Jr. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 2005, 65, 5317–5324.
DOI Google Scholar
[78]

Zhang, X. Y.; Tang, W. J.; Wen, H. Y.; Wu, E. C.; Ding, T. H.; Gu, J.; Lv, Z. W.; Zhan, C. Y. Evaluation of CTB-sLip for targeting lung metastasis of colorectal cancer. Pharmaceutics 2022, 14, 868.
DOI Google Scholar
[79]

Torchilin, V. P. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat. Rev. Drug Discov. 2014, 13, 813–827.
DOI Google Scholar
[80]

Zhang, Z.; Chu, Y. X.; Li, C.; Tang, W. J.; Qian, J.; Wei, X. L.; Lu, W. Y.; Ying, T. L.; Zhan, C. Y. Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines. J. Control. Release 2021, 330, 493–501.
DOI Google Scholar
[81]

Tang, W. J.; Zhang, Z.; Li, C.; Chu, Y. X.; Qian, J.; Ying, T. L.; Lu, W. Y.; Zhan, C. Y. Facile separation of PEGylated liposomes enabled by anti-PEG scFv. Nano Lett. 2021, 21, 10107–10113.
DOI Google Scholar
[82]
Bangham, A. D.; Horne, R. W. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J. Mol. Biol. 1964 , 8, 660–668, IN2–IN10.
DOI
[83]

Large, D. E.; Abdelmessih, R. G.; Fink, E. A.; Auguste, D. T. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv. Drug Deliv. Rev. 2021, 176, 113851.
DOI Google Scholar
[84]

Spector, A. A.; Yorek, M. A. Membrane lipid composition and cellular function. J. Lipid Res. 1985, 26, 1015–1035.
DOI Google Scholar
[85]

Nakhaei, P.; Margiana, R.; Bokov, D. O.; Abdelbasset, W. K.; Jadidi Kouhbanani, M. A.; Varma, R. S.; Marofi, F.; Jarahian, M.; Beheshtkhoo, N. Liposomes: Structure, biomedical applications, and stability parameters with emphasis on cholesterol. Front. Bioeng. Biotechnol. 2021, 9, 705886.
DOI Google Scholar
[86]

Lu, L. W.; Xu, Q. Z.; Wang, J.; Wu, S. Y.; Luo, Z. M.; Lu, W. Y. Drug nanocrystals for active tumor-targeted drug delivery. Pharmaceutics 2022, 14, 797.
DOI Google Scholar
[87]

Dawidczyk, C. M.; Kim, C.; Park, J. H.; Russell, L. M.; Lee, K. H.; Pomper, M. G.; Searson, P. C. State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines. J. Control. Release 2014, 187, 133–144.
DOI Google Scholar
[88]

Boswell, G. W.; Buell, D.; Bekersky, I. AmBisome (liposomal amphotericin B): A comparative review. J. Clin. Pharmacol. 1998, 38, 583–592.
DOI Google Scholar
[89]

Groll, A. H.; Rijnders, B. J. A.; Walsh, T. J.; Adler-Moore, J.; Lewis, R. E.; Brüggemann, R. J. M. Clinical pharmacokinetics, pharmacodynamics, safety and efficacy of liposomal amphotericin B. Clin. Infect. Dis. 2019, 68, S260–S274.
DOI Google Scholar
[90]

Griffith, D. E.; Eagle, G.; Thomson, R.; Aksamit, T. R.; Hasegawa, N.; Morimoto, K.; Addrizzo-Harris, D. J.; O’Donnell, A. E.; Marras, T. K.; Flume, P. A. et al. Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT). A prospective, open-label, randomized study. Am. J. Respir. Crit. Care Med. 2018, 198, 1559–1569.
DOI Google Scholar
[91]

Hutchings, M. I.; Truman, A. W.; Wilkinson, B. Antibiotics: Past, present and future. Curr. Opin. Microbiol. 2019, 51, 72–80.
DOI Google Scholar
[92]

Jeu, L.; Piacenti, F. J.; Lyakhovetskiy, A. G.; Fung, H. B. Voriconazole. Clin. Ther. 2003, 25, 1321–1381.
DOI Google Scholar
[93]

Saravolatz, L. D.; Johnson, L. B.; Kauffman, C. A. Voriconazole: A new triazole antifungal agent. Clin. Infect. Dis. 2003, 36, 630–637.
DOI Google Scholar
[94]

Veloso, D. F. M. C.; Benedetti, N. I. G. M.; Ávila, R. I.; Bastos, T. S. A.; Silva, T. C.; Silva, M. R. R.; Batista, A. C.; Valadares, M. C.; Lima, E. M. Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity. Drug Deliv. 2018, 25, 1585–1594.
DOI Google Scholar
[95]

Walkey, C. D.; Olsen, J. B.; Guo, H. B.; Emili, A.; Chan, W. C. W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 2012, 134, 2139–2147.
DOI Google Scholar
[96]

Moghimi, S. M.; Szebeni, J. Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 2003, 42, 463–478.
DOI Google Scholar
[97]

Wang, H. Y.; Wang, Y. S.; Yuan, C. Z.; Xu, X.; Zhou, W. B.; Huang, Y. H.; Lu, H.; Zheng, Y.; Luo, G.; Shang, J. et al. Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats. NPJ vaccines 2023, 8, 169
DOI Google Scholar
[98]

Barenholz, Y. C. Doxil®-The first FDA-approved nano-drug: Lessons learned. J. Control. Release 2012, 160, 117–134.
DOI Google Scholar
[99]
Najjar, V. A.; Nishioka, K. ‘Tuftsin’: A natural phagocytosis stimulating peptide. Nature 1970 , 228, 672–673.
DOI
[100]

Agrawal, A. K.; Gupta, C. M. Tuftsin-bearing liposomes in treatment of macrophage-based infections. Adv. Drug Deliv. Rev. 2000, 41, 135–146.
DOI Google Scholar
[101]

Wijagkanalan, W.; Kawakami, S.; Takenaga, M.; Igarashi, R.; Yamashita, F.; Hashida, M. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J. Control. Release 2008, 125, 121–130.
DOI Google Scholar
[102]

Li, G. H.; Wang, M. K.; Ding, T. H.; Wang, J.; Chen, T.; Shao, Q. W.; Jiang, K.; Wang, L. P.; Yu, Y. F.; Pan, F. et al. cRGD enables rapid phagocytosis of liposomal vancomycin for intracellular bacterial clearance. J. Control. Release 2022, 344, 202–213.
DOI Google Scholar
[103]

Bogdanowich-Knipp, S. J.; Chakrabarti, S.; Siahaan, T. J.; Williams, T. D.; Dillman, R. K. Solution stability of linear vs. cyclic RGD peptides. J. Pept. Res. 1999, 53, 530–541.
DOI Google Scholar
[104]

Dechantsreiter, M. A.; Planker, E.; Mathä, B.; Lohof, E.; Hölzemann, G.; Jonczyk, A.; Goodman, S. L.; Kessler, H. N-Methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists. J. Med. Chem. 1999, 42, 3033–3040.
DOI Google Scholar
[105]

Nation, R. L.; Li, J. Colistin in the 21st century. Curr. Opin. Infect. Dis. 2009, 22, 535–543.
DOI Google Scholar
[106]

Menina, S.; Eisenbeis, J.; Kamal, M. A. M.; Koch, M.; Bischoff, M.; Gordon, S.; Loretz, B.; Lehr, C. M. Bioinspired liposomes for oral delivery of colistin to combat intracellular infections by Salmonella enterica. Adv. Healthc. Mater. 2019, 8, 1900564.
DOI Google Scholar
[107]

Los, F. C. O.; Randis, T. M.; Aroian, R. V.; Ratner, A. J. Role of pore-forming toxins in bacterial infectious diseases. Microbiol. Mol. Biol. Rev. 2013, 77, 173–207.
DOI Google Scholar
[108]

Henry, B. D.; Neill, D. R.; Becker, K. A.; Gore, S.; Bricio-Moreno, L.; Ziobro, R.; Edwards, M. J.; Mühlemann, K.; Steinmann, J.; Kleuser, B. et al. Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nat. Biotechnol. 2015, 33, 81–88.
DOI Google Scholar
[109]

Filipczak, N.; Pan, J. Y.; Yalamarty, S. S. K.; Torchilin, V. P. Recent advancements in liposome technology. Adv. Drug Deliv. Rev. 2020, 156, 4–22.
DOI Google Scholar
[110]

Kirtane, A. R.; Verma, M.; Karandikar, P.; Furin, J.; Langer, R.; Traverso, G. Nanotechnology approaches for global infectious diseases. Nat. Nanotechnol. 2021, 16, 369–384.
DOI Google Scholar
[111]

Bassetti, M.; Vena, A.; Russo, A.; Peghin, M. Inhaled liposomal antimicrobial delivery in lung infections. Drugs 2020, 80, 1309–1318.
DOI Google Scholar
[112]

Leal, J.; Smyth, H. D. C.; Ghosh, D. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Int. J. Pharm. 2017, 532, 555–572.
DOI Google Scholar
[113]

Roy, I.; Vij, N. Nanodelivery in airway diseases: Challenges and therapeutic applications. Nanomed.: Nanotechnol. Biol. Med. 2010, 6, 237–244.
DOI Google Scholar
[114]

Pornpattananangkul, D.; Zhang, L.; Olson, S.; Aryal, S.; Obonyo, M.; Vecchio, K.; Huang, C. M.; Zhang, L. F. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J. Am. Chem. Soc. 2011, 133, 4132–4139.
DOI Google Scholar
[115]

Giddings, K. S.; Johnson, A. E.; Tweten, R. K. Redefining cholesterol’s role in the mechanism of the cholesterol-dependent cytolysins. Proc. Natl. Acad. Sci. USA 2003, 100, 11315–11320.
DOI Google Scholar
[116]

Dal Peraro, M.; van der Goot, F. G. Pore-forming toxins: Ancient, but never really out of fashion. Nat. Rev. Microbiol. 2016, 14, 77–92.
DOI Google Scholar
[117]

Xie, J. J.; Meng, Z. P.; Han, X. X.; Li, S. P.; Ma, X. N.; Chen, X. Y.; Liang, Y. M.; Deng, X. M.; Xia, K. X.; Zhang, Y. et al. Cholesterol microdomain enhances the biofilm eradication of antibiotic liposomes. Adv. Healthc. Mater. 2022, 11, 2101745.
DOI Google Scholar
[118]

Lai, C. C.; Shih, T. P.; Ko, W. C.; Tang, H. J.; Hsueh, P. R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents 2020, 55, 105924.
DOI Google Scholar
[119]

Wang, N.; Ferhan, A. R.; Yoon, B. K.; Jackman, J. A.; Cho, N. J.; Majima, T. Chemical design principles of next-generation antiviral surface coatings. Chem. Soc. Rev. 2021, 50, 9741–9765.
DOI Google Scholar
[120]

Nasrollahzadeh, M.; Sajjadi, M.; Soufi, G. J.; Iravani, S.; Varma, R. S. Nanomaterials and nanotechnology-associated innovations against viral infections with a focus on coronaviruses. Nanomaterials 2020, 10, 1072.
DOI Google Scholar
[121]

Sen, C. K.; Gordillo, G. M.; Roy, S.; Kirsner, R.; Lambert, L.; Hunt, T. K.; Gottrup, F.; Gurtner, G. C.; Longaker, M. T. Human skin wounds: A major and snowballing threat to public health and the economy. Wound Repair Regen. 2009, 17, 763–771.
DOI Google Scholar
[122]

Chang, R. Y. K.; Morales, S.; Okamoto, Y.; Chan, H. K. Topical application of bacteriophages for treatment of wound infections. Transl. Res. 2020, 220, 153–166.
DOI Google Scholar
[123]

Walsh, T. R.; Efthimiou, J.; Dréno, B. Systematic review of antibiotic resistance in acne: An increasing topical and oral threat. Lancet Infect. Dis. 2016, 16, e23–e33.
DOI Google Scholar
[124]
Thassu, D.; Chader, G. J. Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate Systems; CRC Press: Boca Raton, 2012.
DOI
[125]

Thapa, R. K.; Kiick, K. L.; Sullivan, M. O. Encapsulation of collagen mimetic peptide-tethered vancomycin liposomes in collagen-based scaffolds for infection control in wounds. Acta Biomater. 2020, 103, 115–128.
DOI Google Scholar
[126]

Virgin, H. W.; Wherry, E. J.; Ahmed, R. Redefining chronic viral infection. Cell 2009, 138, 30–50.
DOI Google Scholar
[127]

Paterson, R. R. M.; Lima, N. Filamentous fungal human pathogens from food emphasising Aspergillus, Fusarium and Mucor. Microorganisms 2017, 5, 44.
DOI Google Scholar
[128]

Omar, A.; Wright, J. B.; Schultz, G.; Burrell, R.; Nadworny, P. Microbial biofilms and chronic wounds. Microorganisms 2017, 5, 9.
DOI Google Scholar
[129]

Meers, P.; Neville, M.; Malinin, V.; Scotto, A. W.; Sardaryan, G.; Kurumunda, R.; Mackinson, C.; James, G.; Fisher, S.; Perkins, W. R. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J. Antimicrob. Chemother. 2008, 61, 859–868.
DOI Google Scholar
[130]

Waters, V.; Ratjen, F. Inhaled liposomal amikacin. Expert Rev. Respir. Med. 2014, 8, 401–409.
DOI Google Scholar
[131]

Hemmingsen, L. M.; Giordani, B.; Paulsen, M. H.; Vanić, Ž.; Flaten, G. E.; Vitali, B.; Basnet, P.; Bayer, A.; Strøm, M. B.; Škalko-Basnet, N. Tailored anti-biofilm activity—Liposomal delivery for mimic of small antimicrobial peptide. Biomater. Adv. 2023, 145, 213238.
DOI Google Scholar
[132]

Price, C. I.; Horton, J. W.; Baxter, C. R. Liposome encapsulation: A method for enhancing the effectiveness of local antibiotics. Surgery 1994, 115, 480–487.
Google Scholar
[133]

Price, C. I.; Horton, J. W.; Baxter, C. R. Topical liposomal delivery of antibiotics in soft tissue infection. J. Surg. Res. 1990, 49, 174–178.
DOI Google Scholar
[134]

Chang, T. M. S. Artificial cell evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology. Artif. Cells Nanomed. Biotechnol. 2019, 47, 997–1013.
DOI Google Scholar
[135]

Pandey, N.; Dhiman, S.; Srivastava, T.; Majumder, S. Transition metal oxide nanoparticles are effective in inhibiting lung cancer cell survival in the hypoxic tumor microenvironment. Chem. Biol. Interact. 2016, 254, 221–230.
DOI Google Scholar
[136]

Ai, Y. J.; Hu, Z. N.; Liang, X. P.; Sun, H. B.; Xin, H. B.; Liang, Q. L. Recent advances in nanozymes: From matters to bioapplications. Adv. Funct. Mater. 2022, 32, 2110432.
DOI Google Scholar
[137]

Karthik, A. D.; Geetha, K. Applications of transition metal nanoparticles in antimicrobial therapy. Biomater. Tissue Eng. Bull. 2016, 3, 28–34.
DOI Google Scholar
[138]

Bonda, D. J.; Liu, G.; Men, P.; Perry, G.; Smith, M. A.; Zhu, X. W. Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming! CNS Neurol. Disord. Drug Targets. 2012, 11, 81–85.
DOI Google Scholar
[139]

Molino, N. M.; Wang, S. W. Caged protein nanoparticles for drug delivery. Curr. Opin. Biotechnol. 2014, 28, 75–82.
DOI Google Scholar
[140]

Iqbal, H.; Yang, T.; Li, T.; Zhang, M. Y.; Ke, H. T.; Ding, D. W.; Deng, Y. B.; Chen, H. B. Serum protein-based nanoparticles for cancer diagnosis and treatment. J. Control. Release 2021, 329, 997–1022.
DOI Google Scholar
[141]

Wang, C. S.; Liu, C.; Luo, J. B.; Tian, Y. P.; Zhou, N. D. Direct electrochemical detection of kanamycin based on peroxidase-like activity of gold nanoparticles. Anal. Chim. Acta 2016, 936, 75–82.
DOI Google Scholar
[142]

Weerathunge, P.; Ramanathan, R.; Torok, V. A.; Hodgson, K.; Xu, Y.; Goodacre, R.; Behera, B. K.; Bansal, V. Ultrasensitive colorimetric detection of murine norovirus using NanoZyme aptasensor. Anal. Chem. 2019, 91, 3270–3276.
DOI Google Scholar
[143]

He, W. W.; Zhou, Y. T.; Wamer, W. G.; Hu, X. N.; Wu, X. C.; Zheng, Z.; Boudreau, M. D.; Yin, J. J. Intrinsic catalytic activity of Au nanoparticles with respect to hydrogen peroxide decomposition and superoxide scavenging. Biomaterials 2013, 34, 765–773.
DOI Google Scholar
[144]

Ma, M.; Zhang, Y.; Gu, N. Peroxidase-like catalytic activity of cubic Pt nanocrystals. Colloids Surf. A: Physicochem. Eng. Aspects 2011, 373, 6–10.
DOI Google Scholar
[145]

Cui, M. L.; Zhou, J. D.; Zhao, Y.; Song, Q. J. Facile synthesis of iridium nanoparticles with superior peroxidase-like activity for colorimetric determination of H2O2 and xanthine. Sens. Actuators B: Chem. 2017, 243, 203–210.
DOI Google Scholar
[146]

Shen, X. M.; Liu, W. Q.; Gao, X. J.; Lu, Z. H.; Wu, X. C.; Gao, X. F. Mechanisms of oxidase and superoxide dismutation-like activities of gold, silver, platinum, and palladium, and their alloys: A general way to the activation of molecular oxygen. J. Am. Chem. Soc. 2015, 137, 15882–15891.
DOI Google Scholar
[147]

Glantz, M. J.; Jaeckle, K. A.; Chamberlain, M. C.; Phuphanich, S.; Recht, L.; Swinnen, L. J.; Maria, B.; LaFollette, S.; Schumann, G. B.; Cole, B. F. et al. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin. Cancer Res. 1999, 5, 3394–3402.
Google Scholar
[148]

Tian, J.; Wong, K. K. Y.; Ho, C. M.; Lok, C. N.; Yu, W. Y.; Che, C. M.; Chiu, J. F.; Tam, P. K. H. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2007, 2, 129–136.
DOI Google Scholar
[149]

Santoro, C. M.; Duchsherer, N. L.; Grainger, D. W. Minimal in vitro antimicrobial efficacy and ocular cell toxicity from silver nanoparticles. Nanobiotechnology 2007, 3, 55–65.
DOI Google Scholar
[150]

Divya, M.; Kiran, G. S.; Hassan, S.; Selvin, J. Biogenic synthesis and effect of silver nanoparticles (AgNPs) to combat catheter-related urinary tract infections. Biocatal. Agric. Biotechnol. 2019, 18, 101037.
DOI Google Scholar
[151]

Wang, J. L.; Zhan, L. L.; Zhang, X. H.; Wu, R. F.; Liao, L.; Wei, J. C. Silver nanoparticles coated poly(L-lactide) electrospun membrane for implant associated infections prevention. Front. Pharmacol. 2020, 11, 431.
DOI Google Scholar
[152]

He, W. W.; Zhou, Y. T.; Wamer, W. G.; Boudreau, M. D.; Yin, J. J. Mechanisms of the pH dependent generation of hydroxyl radicals and oxygen induced by Ag nanoparticles. Biomaterials 2012, 33, 7547–7555.
DOI Google Scholar
[153]

He, D.; Jones, A. M.; Garg, S.; Pham, A. N.; Waite, T. D. Silver nanoparticle-reactive oxygen species interactions: Application of a charging-discharging model. J. Phys. Chem. C 2011, 115, 5461–5468.
DOI Google Scholar
[154]

Qing, Y.; Cheng, L.; Li, R. Y.; Liu, G. C.; Zhang, Y. B.; Tang, X. F.; Wang, J. C.; Liu, H.; Qin, Y. G. Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies. Int. J. Nanomedicine 2018, 13, 3311–3327.
DOI Google Scholar
[155]

Murray, R. G. E.; Steed, P.; Elson, H. E. The location of the mucopeptide in sections of the cell wall of escherichia coli and other gram-negative bacteria. Can. J. Microbiol. 1965, 11, 547–560.
DOI Google Scholar
[156]

Lancee, B. The negative side effects of vocational education: A cross-national analysis of the relative unemployment risk of young non-western immigrants in Europe. Am. Behav. Sci. 2016, 60, 659–679.
DOI Google Scholar
[157]

Shockman, G. D.; Barrett, J. F. Structure, function, and assembly of cell walls of gram-positive bacteria. Annu. Rev. Microbiol. 1983, 37, 501–527.
DOI Google Scholar
[158]

Gupta, P.; Bajpai, M.; Bajpai, S. K. Investigation of antibacterial properties of silver nanoparticle-loaded poly (acrylamide-co-itaconic acid)-grafted cotton fabric. J. Cotton Sci. 2008, 12, 280–286.
Google Scholar
[159]

Alula, M. T. Peroxidase-like activity of biosynthesized silver nanoparticles for colorimetric detection of cysteine. RSC Adv. 2023, 13, 16396–16404.
DOI Google Scholar
[160]

Tran, H. V.; Nguyen, N. D.; Tran, C. T. Q.; Tran, L. T.; Le, T. D.; Tran, H. T. T.; Piro, B.; Huynh, C. D.; Nguyen, T. N.; Nguyen, N. T. T. et al. Silver nanoparticles-decorated reduced graphene oxide: A novel peroxidase-like activity nanomaterial for development of a colorimetric glucose biosensor. Arab. J. Chem. 2020, 13, 6084–6091.
DOI Google Scholar
[161]

Tran, H. V.; Nguyen, T. V.; Nguyen, L. T. N.; Hoang, H. S.; Huynh, C. D. Silver nanoparticles as a bifunctional probe for label-free and reagentless colorimetric hydrogen peroxide chemosensor and cholesterol biosensor. J. Sci.: Adv. Mater. Devices 2020, 5, 385–391.
DOI Google Scholar
[162]

Lemire, J. A.; Harrison, J. J.; Turner, R. J. Antimicrobial activity of metals: Mechanisms, molecular targets and applications. Nat. Rev. Microbiol. 2013, 11, 371–384.
DOI Google Scholar
[163]

Silver, S. Bacterial silver resistance: Molecular biology and uses and misuses of silver compounds. FEMS Microbiol. Rev. 2003, 27, 341–353.
DOI Google Scholar
[164]

Percival, S. L.; Bowler, P. G.; Russell, D. Bacterial resistance to silver in wound care. J. Hosp. Infect. 2005, 60, 1–7.
DOI Google Scholar
[165]

Shahverdi, A. R.; Fakhimi, A.; Shahverdi, H. R.; Minaian, S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomed.: Nanotechnol. Biol. Med. 2007, 3, 168–171.
DOI Google Scholar
[166]

Umapathi, A.; Nagaraju, N. P.; Madhyastha, H.; Jain, D.; Srinivas, S. P.; Rotello, V. M.; Daima, H. K. Highly efficient and selective antimicrobial isonicotinylhydrazide-coated polyoxometalate-functionalized silver nanoparticles. Colloids Surf. B: Biointerfaces 2019, 184, 110522.
DOI Google Scholar
[167]

Yamase, T. Anti-tumor, -viral, and -bacterial activities of polyoxometalates for realizing an inorganic drug. J. Mater. Chem. 2005, 15, 4773–4782.
DOI Google Scholar
[168]

Lee, S. H.; Jun, B. H. Silver nanoparticles: Synthesis and application for nanomedicine. Int. J. Mol. Sci. 2019, 20, 865.
DOI Google Scholar
[169]

Liu, Y. T.; Duan, Z. Q.; Xie, X. M.; Ye, X. Y. A universal strategy for the hierarchical assembly of functional 0/2D nanohybrids. Chem. Commun. 2013, 49, 1642–1644.
DOI Google Scholar
[170]

Deshmukh, A. R.; Aloui, H.; Kim, B. S. In situ growth of gold and silver nanoparticles onto phyto-functionalized boron nitride nanosheets: Catalytic, peroxidase mimicking, and antimicrobial activity. J. Clean. Prod. 2020, 270, 122339.
DOI Google Scholar
[171]

Hsu, C. L.; Li, Y. J.; Jian, H. J.; Harroun, S. G.; Wei, S. C.; Ravindranath, R.; Lai, J. Y.; Huang, C. C.; Chang, H. T. Green synthesis of catalytic gold/bismuth oxyiodide nanocomposites with oxygen vacancies for treatment of bacterial infections. Nanoscale 2018, 10, 11808–11819.
DOI Google Scholar
[172]

Deng, H. H.; Luo, B. Y.; He, S. B.; Chen, R. T.; Lin, Z.; Peng, H. P.; Xia, X. H.; Chen, W. Redox recycling-triggered peroxidase-like activity enhancement of bare gold nanoparticles for ultrasensitive colorimetric detection of rare-earth Ce3+ ion. Anal. Chem. 2019, 91, 4039–4046.
DOI Google Scholar
[173]

Zheng, Y. K.; Liu, W. W.; Qin, Z. J.; Chen, Y.; Jiang, H.; Wang, X. M. Mercaptopyrimidine-conjugated gold nanoclusters as nanoantibiotics for combating multidrug-resistant superbugs. Bioconjug. Chem. 2018, 29, 3094–3103.
DOI Google Scholar
[174]

Lorenzana-Vázquez, G.; Pavel, I.; Meléndez, E. Gold nanoparticles functionalized with 2-thiouracil for antiproliferative and photothermal therapies in breast cancer cells. Molecules 2023, 28, 4453.
DOI Google Scholar
[175]

Zhang, S. N.; Lu, Q. J.; Wang, F. Y.; Xiao, Z. Y.; He, L. D.; He, D. G.; Deng, L. Gold-platinum nanodots with high-peroxidase-like activity and photothermal conversion efficiency for antibacterial therapy. ACS Appl. Mater. Interfaces 2021, 13, 37535–37544.
DOI Google Scholar
[176]

Chen, J. X.; Ma, Q.; Li, M. H.; Chao, D. Y.; Huang, L.; Wu, W. W.; Fang, Y. X.; Dong, S. J. Glucose-oxidase like catalytic mechanism of noble metal nanozymes. Nat. Commun. 2021, 12, 3375.
DOI Google Scholar
[177]

Das, R.; Dhiman, A.; Kapil, A.; Bansal, V.; Sharma, T. K. Aptamer-mediated colorimetric and electrochemical detection of Pseudomonas aeruginosa utilizing peroxidase-mimic activity of gold NanoZyme. Anal. Bioanal. Chem. 2019, 411, 1229–1238.
DOI Google Scholar
[178]

Liu, M. Y.; Zhang, F. J.; Dou, S. Y.; Sun, J. S.; Vriesekoop, F.; Li, F. L.; Guo, Y. M.; Sun, X. Label-free colorimetric apta-assay for detection of Escherichia coli based on gold nanoparticles with peroxidase-like amplification. Anal. Methods 2023, 15, 1661–1667.
DOI Google Scholar
[179]

Xue, J. W.; Wang, R.; Yang, J. Y.; Wang, L. X.; Cao, Y.; Li, H. D.; Yang, T.; Wang, J. H. Sensitive plasmonic ELISA assay based on butyrylcholinesterase catalyzed hydrolysis for the detection of Staphylococcus aureus. Sens. Actuators B: Chem. 2022, 365, 131948.
DOI Google Scholar
[180]

Yao, S.; Li, J.; Pang, B.; Wang, X. C.; Shi, Y. J.; Song, X. L.; Xu, K.; Wang, J.; Zhao, C. Colorimetric immunoassay for rapid detection of Staphylococcus aureus based on etching-enhanced peroxidase-like catalytic activity of gold nanoparticles. Microchim. Acta 2020, 187, 504.
DOI Google Scholar
[181]

Aithal, S.; Mishriki, S.; Gupta, R.; Sahu, R. P.; Botos, G.; Tanvir, S.; Hanson, R. W.; Puri, I. K. SARS-CoV-2 detection with aptamer-functionalized gold nanoparticles. Talanta 2022, 236, 122841.
DOI Google Scholar
[182]

Ahmed, S. R.; Kim, J.; Suzuki, T.; Lee, J.; Park, E. Y. Detection of influenza virus using peroxidase-mimic of gold nanoparticles. Biotechnol. Bioeng. 2016, 113, 2298–2303.
DOI Google Scholar
[183]

Jiang, T.; Song, Y.; Wei, T. X.; Li, H.; Du, D.; Zhu, M. J.; Lin, Y. H. Sensitive detection of Escherichia coli O157:H7 using Pt-Au bimetal nanoparticles with peroxidase-like amplification. Biosens. Bioelectron. 2016, 77, 687–694.
DOI Google Scholar
[184]

Jung, B. Y.; Jung, S. C.; Kweon, C. H. Development of a rapid immunochromatographic strip for detection of Escherichia coli O157. J. Food Prot. 2005, 68, 2140–2143.
DOI Google Scholar
[185]

Lee, I.; Delbecq, F.; Morales, R.; Albiter, M. A.; Zaera, F. Tuning selectivity in catalysis by controlling particle shape. Nat. Mater. 2009, 8, 132–138.
DOI Google Scholar
[186]

Huang, X. Q.; Zhao, Z. P.; Fan, J. M.; Tan, Y. M.; Zheng, N. F. Amine-assisted synthesis of concave polyhedral platinum nanocrystals having {411} high-index facets. J. Am. Chem. Soc. 2011, 133, 4718–4721.
DOI Google Scholar
[187]

Fang, G.; Li, W. F.; Shen, X. M.; Perez-Aguilar, J. M.; Chong, Y.; Gao, X. F.; Chai, Z. F.; Chen, C. Y.; Ge, C. C.; Zhou, R. H. Differential Pd-nanocrystal facets demonstrate distinct antibacterial activity against Gram-positive and Gram-negative bacteria. Nat. Commun. 2018, 9, 129.
DOI Google Scholar
[188]

Xiang, S. J.; Fan, Z. X.; Sun, D.; Zhu, T. B.; Ming, J.; Chen, X. L. Near-infrared light enhanced peroxidase-like activity of PEGylated palladium nanozyme for highly efficient biofilm eradication. J. Biomed. Nanotechnol. 2021, 17, 1131–1147.
DOI Google Scholar
[189]

Guo, J. X.; Wei, W. Y.; Zhao, Y. N.; Dai, H. L. Iron oxide nanoparticles with photothermal performance and enhanced nanozyme activity for bacteria-infected wound therapy. Regen. Biomater. 2022, 9, rbac041.
DOI Google Scholar
[190]

Liu, C.; Zhang, M.; Geng, H. Q.; Zhang, P.; Zheng, Z.; Zhou, Y. L.; He, W. W. NIR enhanced peroxidase-like activity of Au@CeO2 hybrid nanozyme by plasmon-induced hot electrons and photothermal effect for bacteria killing. Appl. Catal. B: Environ. 2021, 295, 120317.
DOI Google Scholar
[191]

Li, Z. P.; Xu, D. Q.; Deng, Z. A.; Yin, J. N.; Qian, Y. N.; Hou, J. T.; Ding, X.; Shen, J. L.; He, X. J. Single-atom-catalyzed MXene-based nanoplatform with photo-enhanced peroxidase-like activity nanotherapeutics for Staphylococcus aureus infection. Chem. Eng. J. 2023, 452, 139587.
DOI Google Scholar
[192]

Huang, T.; Yu, Z.; Yuan, B.; Jiang, L.; Liu, Y.; Sun, X.; Liu, P.; Jiang, W.; Tang, J. Synergy of light-controlled Pd nanozymes with NO therapy for biofilm elimination and diabetic wound treatment acceleration. Mater. Today Chem. 2022, 24, 100831.
DOI Google Scholar
[193]

Ma, M. H.; Wang, R. X.; Xu, L. N.; Du, J. J.; Xu, M.; Liu, S. J. Emerging investigator series: Enhanced peroxidase-like activity and improved antibacterial performance of palladium nanosheets by an alginate-corona. Environ. Sci.: Nano 2021, 8, 3511–3523.
DOI Google Scholar
[194]

Khalil, M. M. H.; Ismail, E. H.; El-Magdoub, F. Biosynthesis of Au nanoparticles using olive leaf extract: 1st Nano Updates. Arab. J. Chem. 2012, 5, 431–437.
DOI Google Scholar
[195]

Lang, J. Y.; Ma, X. J.; Chen, P. Y.; Serota, M. D.; Andre, N. M.; Whittaker, G. R.; Yang, R. Haloperoxidase-mimicking CeO2− x nanorods for the deactivation of human coronavirus OC43. Nanoscale 2022, 14, 3731–3737.
DOI Google Scholar
[196]

Chen, J.; Zhang, S.; Chen, X.; Wang, L. Y.; Yang, W. S. A self-assembled fmoc-diphenylalanine hydrogel-encapsulated Pt nanozyme as oxidase- and peroxidase-like breaking pH limitation for potential antimicrobial application. Chem. -Eur. J. 2022, 28, e202104247.
DOI Google Scholar
[197]

Ranu, B. C.; Dey, R.; Chatterjee, T.; Ahammed, S. Copper nanoparticle-catalyzed carbon–carbon and carbon–heteroatom bond formation with a greener perspective. ChemSusChem 2012, 5, 22–44.
DOI Google Scholar
[198]

Allen, S. E.; Walvoord, R. R.; Padilla-Salinas, R.; Kozlowski, M. C. Aerobic copper-catalyzed organic reactions. Chem. Rev. 2013, 113, 6234–6458.
DOI Google Scholar
[199]

Amadine, O.; Maati, H.; Abdelouhadi, K.; Fihri, A.; El Kazzouli, S.; Len, C.; El Bouari, A.; Solhy, A. Ceria-supported copper nanoparticles: A highly efficient and recyclable catalyst for N-arylation of indole. J. Mol. Catal. A: Chem. 2014, 395, 409–419.
DOI Google Scholar
[200]

Gu, M.; Bode, D. C.; Viles, J. H. Copper redox cycling inhibits Aβ fibre formation and promotes fibre fragmentation, while generating a dityrosine Aβ dimer. Sci. Rep. 2018, 8, 16190.
DOI Google Scholar
[201]

Dai, X. M.; Zhao, Y.; Yu, Y. J.; Chen, X. L.; Wei, X. S.; Zhang, X. G.; Li, C. X. Single continuous near-infrared laser-triggered photodynamic and photothermal ablation of antibiotic-resistant bacteria using effective targeted copper sulfide nanoclusters. ACS Appl. Mater. Interfaces 2017, 9, 30470–30479.
DOI Google Scholar
[202]

He, X. J.; Rong, S.; Jin, Y. R.; Zhang, R. P. Copper-doped melanin nanozyme with enhanced photothermal and peroxidase-like catalytic property for synergistic antimicrobial effect. Mater. Lett. 2023, 341, 134226.
DOI Google Scholar
[203]

Pecci, L.; Montefoschi, G.; Cavallini, D. Some new details of the copper–hydrogen peroxide interaction. Biochem. Biophys. Res. Commun. 1997, 235, 264–267.
DOI Google Scholar
[204]

Yilmaz, S. G.; Demirbas, A.; Karaagac, Z.; Dadi, S.; Celik, C.; Yusufbeyoglu, S.; Ildiz, N.; Mandal, A. K.; Cimen, B.; Ocsoy, I. Synthesis of taurine-Cu3(PO4)2 hybrid nanoflower and their peroxidase-mimic and antimicrobial properties. J. Biotechnol. 2022, 343, 96–101.
DOI Google Scholar
[205]

Wang, L.; Hou, J. J.; Liu, S. Z.; Carrier, A. J.; Guo, T.; Liang, Q. S.; Oakley, D.; Zhang, X. CuO nanoparticles as haloperoxidase-mimics: Chloride-accelerated heterogeneous Cu-Fenton chemistry for H2O2 and glucose sensing. Sens. Actuators B: Chem. 2019, 287, 180–184.
DOI Google Scholar
[206]

Zhuang, Q. Q.; Deng, Q.; He, S. B.; Chen, Q. Q.; Peng, H. P.; Deng, H. H.; Xia, X. H.; Chen, W. Bifunctional cupric oxide nanoparticle-catalyzed self-cascade oxidation reactions of ascorbic acid for bacterial killing and wound disinfection. Compos. Part B: Eng. 2021, 222, 109074.
DOI Google Scholar
[207]

Xie, Y. X.; Qian, Y.; Li, Z. X.; Liang, Z. C.; Liu, W. F.; Yang, D. J.; Qiu, X. Q. Near-infrared-activated efficient bacteria-killing by lignin-based copper sulfide nanocomposites with an enhanced photothermal effect and peroxidase-like activity. ACS Sustain. Chem. Eng. 2021, 9, 6479–6488.
DOI Google Scholar
[208]

Xie, Y. X.; Gan, C. C.; Li, Z. X.; Liu, W. F.; Yang, D. J.; Qiu, X. Q. Fabrication of a lignin-copper sulfide-incorporated PVA hydrogel with near-infrared-activated photothermal/photodynamic/peroxidase-like performance for combating bacteria and biofilms. ACS Biomater. Sci. Eng. 2022, 8, 560–569.
DOI Google Scholar
[209]

Xi, J. Q.; Wei, G.; An, L. F.; Xu, Z. B.; Xu, Z. L.; Fan, L.; Gao, L. Z. Copper/carbon hybrid nanozyme: Tuning catalytic activity by the copper state for antibacterial therapy. Nano Lett. 2019, 19, 7645–7654.
DOI Google Scholar
[210]

Cuevas, R.; Durán, N.; Diez, M. C.; Tortella, G. R.; Rubilar, O. Extracellular biosynthesis of copper and copper oxide nanoparticles by Stereum hirsutum, a native white-rot fungus from chilean forests. J. Nanomater. 2015, 2015, 789089.
DOI Google Scholar
[211]

Ovais, M.; Khalil, A. T.; Raza, A.; Islam, N. U.; Ayaz, M.; Saravanan, M.; Ali, M.; Ahmad, I.; Shahid, M.; Shinwari, Z. K. Multifunctional theranostic applications of biocompatible green-synthesized colloidal nanoparticles. Appl. Microbiol. Biotechnol. 2018, 102, 4393–4408.
DOI Google Scholar
[212]

Asghar, M.; Sajjad, A.; Hanif, S.; Ali, J. S.; Ali, Z.; Zia, M. Comparative analysis of synthesis, characterization, antimicrobial, antioxidant, and enzyme inhibition potential of roses petal based synthesized copper oxide nanoparticles. Mater. Chem. Phys. 2022, 278, 125724.
DOI Google Scholar
[213]

Iqbal, J.; Andleeb, A.; Ashraf, H.; Meer, B.; Mehmood, A.; Jan, H.; Zaman, G.; Nadeem, M.; Drouet, S.; Fazal, H. et al. Potential antimicrobial, antidiabetic, catalytic, antioxidant and ROS/RNS inhibitory activities of Silybum marianum mediated biosynthesized copper oxide nanoparticles. RSC Adv. 2022, 12, 14069–14083.
DOI Google Scholar
[214]

Lim, J.; Majetich, S. A. Composite magnetic-plasmonic nanoparticles for biomedicine: Manipulation and imaging. Nano Today 2013, 8, 98–113.
DOI Google Scholar
[215]

Ansari, S. M.; Bhor, R. D.; Pai, K. R.; Sen, D.; Mazumder, S.; Ghosh, K.; Kolekar, Y. D.; Ramana, C. V. Cobalt nanoparticles for biomedical applications: Facile synthesis, physiochemical characterization, cytotoxicity behavior and biocompatibility. Appl. Surf. Sci. 2017, 414, 171–187.
DOI Google Scholar
[216]

Shi, J. C.; Shu, R.; Shi, X. Y.; Li, Y. F.; Li, J. G.; Deng, Y.; Yang, W. Z. Multi-activity cobalt ferrite/MXene nanoenzymes for drug-free phototherapy in bacterial infection treatment. RSC Adv. 2022, 12, 11090–11099.
DOI Google Scholar
[217]

He, S. Y.; Huang, J. Q.; Zhang, Q.; Zhao, W.; Xu, Z. A.; Zhang, W. Bamboo-like nanozyme based on nitrogen-doped carbon nanotubes encapsulating cobalt nanoparticles for wound antibacterial applications. Adv. Funct. Mater. 2021, 31, 2105198.
DOI Google Scholar
[218]

Zhan, Y. J.; Yu, Y.; Wu, P.; Ding, P. Study on the synthesis and antibacterial activity of cobalt-metal organic framework. J. Phys.: Conf. Ser. 2022, 2393, 012034.
DOI Google Scholar
[219]

Lombardo Lupano, L. V.; Lázaro Martínez, J. M.; Piehl, L. L.; Rubin de Celis, E.; Campo Dall’ Orto, V. Activation of H2O2 and superoxide production using a novel cobalt complex based on a polyampholyte. Appl. Catal. A: Gen. 2013, 467, 342–354.
DOI Google Scholar
[220]

Mirhosseini, M.; Shekari-Far, A.; Hakimian, F.; Haghiralsadat, B. F.; Fatemi, S. K.; Dashtestani, F. Core–shell Au@Co-Fe hybrid nanoparticles as peroxidase mimetic nanozyme for antibacterial application. Process Biochem. 2020, 95, 131–138.
DOI Google Scholar
[221]

Wang, Y.; Chen, C.; Zhang, D.; Wang, J. Bifunctionalized novel Co-V MMO nanowires: Intrinsic oxidase and peroxidase like catalytic activities for antibacterial application. Appl. Catal. B: Environ. 2020, 261, 118256.
DOI Google Scholar
[222]

Liu, J. L.; Wang, Y. H.; Shen, J. H.; Liu, H.; Li, J. Q.; Wang, A. Q.; Hui, A. P.; Munir, H. A. Superoxide anion: Critical source of high performance antibacterial activity in Co-doped ZnO QDs. Ceram. Int. 2020, 46, 15822–15830.
DOI Google Scholar
[223]

Li, D. D.; Guo, Q. Q.; Ding, L. M.; Zhang, W.; Cheng, L.; Wang, Y. Q.; Xu, Z. B.; Wang, H. H.; Gao, L. Z. Bimetallic CuCo2S4 nanozymes with enhanced peroxidase activity at neutral ph for combating burn infections. ChemBioChem 2020, 21, 2620–2627.
DOI Google Scholar
[224]

Chen, Z. W.; Yin, J. J.; Zhou, Y. T.; Zhang, Y.; Song, L. N.; Song, M. J.; Hu, S. L.; Gu, N. Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity. ACS Nano 2012, 6, 4001–4012.
DOI Google Scholar
[225]

Wei, H.; Wang, E. K. Nanomaterials with enzyme-like characteristics (nanozymes): Next-generation artificial enzymes. Chem. Soc. Rev. 2013, 42, 6060–6093.
DOI Google Scholar
[226]

Dong, H. J.; Du, W.; Dong, J.; Che, R. C.; Kong, F.; Cheng, W. L.; Ma, M.; Gu, N.; Zhang, Y. Depletable peroxidase-like activity of Fe3O4 nanozymes accompanied with separate migration of electrons and iron ions. Nat. Commun. 2022, 13, 5365.
DOI Google Scholar
[227]

Kumar, R.; Sahoo, G. C.; Chawla-Sarkar, M.; Nayak, M. K.; Trivedi, K.; Rana, S.; Pandey, K.; Das, V.; Topno, R.; Das, P. Antiviral effect of glycine coated iron oxide nanoparticles iron against H1N1 influenza A virus. Int. J. Infect. Dis. 2016, 45, 281–282.
DOI Google Scholar
[228]

Kumar, R.; Nayak, M.; Sahoo, G. C.; Pandey, K.; Sarkar, M. C.; Ansari, Y.; Das, V. N. R.; Topno, R. K.; Bhawna; Madhukar, M. et al. Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus. J. Infect. Chemother. 2019, 25, 325–329.
DOI Google Scholar
[229]

Qin, T.; Ma, R. N.; Yin, Y. Y.; Miao, X. Y.; Chen, S. J.; Fan, K. L.; Xi, J. Q.; Liu, Q.; Gu, Y. H.; Yin, Y. C. et al. Catalytic inactivation of influenza virus by iron oxide nanozyme. Theranostics 2019, 9, 6920–6935.
DOI Google Scholar
[230]

Naha, P. C.; Liu, Y.; Hwang, G.; Huang, Y.; Gubara, S.; Jonnakuti, V.; Simon-Soro, A.; Kim, D.; Gao, L. Z.; Koo, H. et al. Dextran-coated iron oxide nanoparticles as biomimetic catalysts for localized and pH-activated biofilm disruption. ACS Nano 2019, 13, 4960–4971.
DOI Google Scholar
[231]

Wang, Y. Q.; Shen, X. Y.; Ma, S.; Guo, Q. Q.; Zhang, W.; Cheng, L.; Ding, L. M.; Xu, Z. B.; Jiang, J.; Gao, L. Z. Oral biofilm elimination by combining iron-based nanozymes and hydrogen peroxide-producing bacteria. Biomater. Sci. 2020, 8, 2447–2458.
DOI Google Scholar
[232]

Vallabani, N. V. S.; Vinu, A.; Singh, S.; Karakoti, A. Tuning the ATP-triggered pro-oxidant activity of iron oxide-based nanozyme towards an efficient antibacterial strategy. J. Colloid Interface Sci. 2020, 567, 154–164.
DOI Google Scholar
[233]

Vallabani, N. V. S.; Karakoti, A. S.; Singh, S. ATP-mediated intrinsic peroxidase-like activity of Fe3O4-based nanozyme: One step detection of blood glucose at physiological pH. Colloids Surf. B: Biointerfaces 2017, 153, 52–60.
DOI Google Scholar
[234]

Liu, Z. W.; Zhao, X. Y.; Yu, B. R.; Zhao, N. N.; Zhang, C.; Xu, F. J. Rough carbon-iron oxide nanohybrids for near-infrared-II light-responsive synergistic antibacterial therapy. ACS Nano 2021, 15, 7482–7490.
DOI Google Scholar
[235]

Zhang, W.; Hu, S. L.; Yin, J. J.; He, W. W.; Lu, W.; Ma, M.; Gu, N.; Zhang, Y. Prussian blue nanoparticles as multienzyme mimetics and reactive oxygen species scavengers. J. Am. Chem. Soc. 2016, 138, 5860–5865.
DOI Google Scholar
[236]

Dacarro, G.; Taglietti, A.; Pallavicini, P. Prussian blue nanoparticles as a versatile photothermal tool. Molecules 2018, 23, 1414.
DOI Google Scholar
[237]

Maaoui, H.; Jijie, R.; Pan, G. H.; Drider, D.; Caly, D.; Bouckaert, J.; Dumitrascu, N.; Chtourou, R.; Szunerits, S.; Boukherroub, R. A 980 nm driven photothermal ablation of virulent and antibiotic resistant Gram-positive and Gram-negative bacteria strains using Prussian blue nanoparticles. J. Colloid Interface Sci. 2016, 480, 63–68.
DOI Google Scholar
[238]

Chakraborty, N.; Jha, D.; Gautam, H. K.; Roy, I. Peroxidase-like behavior and photothermal effect of chitosan-coated Prussian-blue nanoparticles: Dual-modality antibacterial action with enhanced bioaffinity. Mater. Adv. 2020, 1, 774–782.
DOI Google Scholar
[239]

Li, Y. T.; Zhu, Y.; Wang, C.; Shen, Y.; Liu, L.; Zhou, S. W.; Cui, P. F.; Hu, H. A. Z.; Jiang, P. J.; Ni, X. Y. et al. Mild hyperthermia induced by hollow mesoporous prussian blue nanoparticles in alliance with a low concentration of hydrogen peroxide shows powerful antibacterial effect. Mol. Pharm. 2022, 19, 819–830.
DOI Google Scholar
[240]

Gao, F.; Li, X. L.; Zhang, T. B.; Ghosal, A.; Zhang, G. F.; Fan, H. M.; Zhao, L. Y. Iron nanoparticles augmented chemodynamic effect by alternative magnetic field for wound disinfection and healing. J. Control. Release 2020, 324, 598–609.
DOI Google Scholar
[241]

Le, T. N.; Tran, T. D.; Kim, M. I. A convenient colorimetric bacteria detection method utilizing chitosan-coated magnetic nanoparticles. Nanomaterials 2020, 10, 92.
DOI Google Scholar
[242]

Zakharzhevskii, M.; Drozdov, A. S.; Kolchanov, D. S.; Shkodenko, L.; Vinogradov, V. V. Test-system for bacteria sensing based on peroxidase-like activity of inkjet-printed magnetite nanoparticles. Nanomaterials 2020, 10, 313.
DOI Google Scholar
[243]

Park, J. Y.; Jeong, H. Y.; Kim, M. I.; Park, T. J. Colorimetric detection system for Salmonella typhimurium based on peroxidase-like activity of magnetic nanoparticles with DNA aptamers. J. Nanomater. 2015, 2015, 527126.
DOI Google Scholar
[244]

Heckert, E. G.; Karakoti, A. S.; Seal, S.; Self, W. T. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 2008, 29, 2705–2709.
DOI Google Scholar
[245]

Pirmohamed, T.; Dowding, J. M.; Singh, S.; Wasserman, B.; Heckert, E.; Karakoti, A. S.; King, J. E. S.; Seal, S.; Self, W. T. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem. Commun. 2010, 46, 2736–2738.
DOI Google Scholar
[246]

Frerichs, H.; Pütz, E.; Pfitzner, F.; Reich, T.; Gazanis, A.; Panthöfer, M.; Hartmann, J.; Jegel, O.; Heermann, R.; Tremel, W. Nanocomposite antimicrobials prevent bacterial growth through the enzyme-like activity of Bi-doped cerium dioxide (Ce1− x Bi x O2− δ ). Nanoscale 2020, 12, 21344–21358.
DOI Google Scholar
[247]

Xie, J. X.; Zhang, X. D.; Wang, H.; Zheng, H. Z.; Huang, Y. M.; Xie, J. X. Analytical and environmental applications of nanoparticles as enzyme mimetics. TrAC Trends Anal. Chem. 2012, 39, 114–129.
DOI Google Scholar
[248]

Chishti, B.; Fouad, H.; Seo, H. K.; Alothman, O. Y.; Ansari, Z. A.; Ansari, S. G. ATP fosters the tuning of nanostructured CeO2 peroxidase-like activity for promising antibacterial performance. New J. Chem. 2020, 44, 11291–11303.
DOI Google Scholar
[249]

Herget, K.; Hubach, P.; Pusch, S.; Deglmann, P.; Götz, H.; Gorelik, T. E.; Gural’skiy, I. A.; Pfitzner, F.; Link, T.; Schenk, S. et al. Haloperoxidase mimicry by CeO2− x nanorods combats biofouling. Adv. Mater. 2017, 29, 1603823.
DOI Google Scholar
[250]

Zeng, X. L.; Wang, H. R.; Ma, Y. T.; Xu, X.; Lu, X. X.; Hu, Y. J.; Xie, J. H.; Wang, X.; Wang, Y. S.; Guo, X. L. et al. Vanadium oxide nanozymes with multiple enzyme-mimic activities for tumor catalytic therapy. ACS Appl. Mater. Interfaces 2023, 15, 13941–13955.
DOI Google Scholar
[251]

Ma, W. S.; Zhang, T. T.; Li, R. G.; Niu, Y. S.; Yang, X. C.; Liu, J.; Xu, Y. H.; Li, C. M. Bienzymatic synergism of vanadium oxide nanodots to efficiently eradicate drug-resistant bacteria during wound healing in vivo. J. Colloid Interface Sci. 2020, 559, 313–323.
DOI Google Scholar
[252]

Wever, R.; Tromp, M. G. M.; Krenn, B. E.; Marjani, A.; Van Tol, M. Brominating activity of the seaweed ascophyllum nodosum: Impact on the biosphere. Environ. Sci. Technol. 1991, 25, 446–449.
DOI Google Scholar
[253]

Natalio, F.; André, R.; Hartog, A. F.; Stoll, B.; Jochum, K. P.; Wever, R.; Tremel, W. Vanadium pentoxide nanoparticles mimic vanadium haloperoxidases and thwart biofilm formation. Nat. Nanotechnol. 2012, 7, 530–535.
DOI Google Scholar
[254]

Sun, X. S.; He, X. J.; Zhu, Y.; Obeng, E.; Zeng, B. R.; Deng, H.; Shen, J. L.; Hu, R. D. Valence-switchable and biocatalytic vanadium-based MXene nanoplatform with photothermal-enhanced dual enzyme-like activities for anti-infective therapy. Chem. Eng. J. 2023, 451, 138985.
DOI Google Scholar
[255]

Haque, S.; Tripathy, S.; Patra, C. R. Manganese-based advanced nanoparticles for biomedical applications: Future opportunity and challenges. Nanoscale 2021, 13, 16405–16426.
DOI Google Scholar
[256]

Wang, P.; Yang, J.; Zhou, B. Q.; Hu, Y.; Xing, L. X.; Xu, F. L.; Shen, M. W.; Zhang, G. X.; Shi, X. Y. Antifouling manganese oxide nanoparticles: Synthesis, characterization, and applications for enhanced MR imaging of tumors. ACS Appl. Mater. Interfaces 2017, 9, 47–53.
DOI Google Scholar
[257]

Chen, F.; Bai, M.; Cao, K.; Zhao, Y.; Wei, J.; Zhao, Y. X. Fabricating MnO2 nanozymes as intracellular catalytic DNA circuit generators for versatile imaging of base-excision repair in living cells. Adv. Funct. Mater. 2017, 27, 1702748.
DOI Google Scholar
[258]

Han, L.; Zhang, H. J.; Chen, D. Y.; Li, F. Protein-directed metal oxide nanoflakes with tandem enzyme-like characteristics: Colorimetric glucose sensing based on one-pot enzyme-free cascade catalysis. Adv. Funct. Mater. 2018, 28, 1800018.
DOI Google Scholar
[259]

Zhang, J. Y.; Wu, S. H.; Lu, X. M.; Wu, P.; Liu, J. W. Manganese as a catalytic mediator for photo-oxidation and breaking the pH limitation of nanozymes. Nano Lett. 2019, 19, 3214–3220.
DOI Google Scholar
[260]

Yao, J.; Cheng, Y.; Zhou, M.; Zhao, S.; Lin, S. C.; Wang, X. Y.; Wu, J. J. X.; Li, S. R.; Wei, H. ROS scavenging Mn3O4 nanozymes for in vivo anti-inflammation. Chem. Sci. 2018, 9, 2927–2933.
DOI Google Scholar
[261]

Su, J.; Lyu, T.; Cooper, M.; Mortimer, R. J. G.; Pan, G. Efficient arsenic removal by a bifunctional heterogeneous catalyst through simultaneous hydrogen peroxide (H2O2) catalytic oxidation and adsorption. J. Clean. Prod. 2021, 325, 129329.
DOI Google Scholar
[262]

Xu, W.; Sun, B. H.; Wu, F.; Mohammadniaei, M.; Song, Q. X.; Han, X.; Wang, W. T.; Zhang, M.; Zhou, N. L.; Shen, J. Manganese single-atom catalysts for catalytic-photothermal synergistic anti-infected therapy. Chem. Eng. J. 2022, 438, 135636.
DOI Google Scholar
[263]

Liu, L.; Wang, C.; Li, Y. T.; Qiu, L.; Zhou, S. W.; Cui, P. F.; Jiang, P. J.; Ni, X. Y.; Liu, R. H.; Du, X. C. et al. Manganese dioxide nanozyme for reactive oxygen therapy of bacterial infection and wound healing. Biomater. Sci. 2021, 9, 5965–5976.
DOI Google Scholar
[264]

Zu, Y.; Yao, H. Q.; Wang, Y. F.; Yan, L.; Gu, Z. J.; Chen, C. Y.; Gao, L. Z.; Yin, W. Y. The age of bioinspired molybdenum-involved nanozymes: Synthesis, catalytic mechanisms, and biomedical applications. View 2021, 2, 20200188.
DOI Google Scholar
[265]

Lin, T. R.; Jiang, G. Y.; Lin, D. X.; Lai, Y. P.; Hou, L.; Zhao, S. L. Bacitracin-functionalized dextran-MoSe2 with peroxidase-like and near-infrared photothermal activities for low-temperature and synergetic antibacterial applications. ACS Appl. Bio Mater. 2022, 5, 2347–2354.
DOI Google Scholar
[266]

Tan, J.; Wu, S. Y.; Cai, Q. Q.; Wang, Y.; Zhang, P. Reversible regulation of enzyme-like activity of molybdenum disulfide quantum dots for colorimetric pharmaceutical analysis. J. Pharm. Anal. 2022, 12, 113–121.
DOI Google Scholar
[267]

Cao, M. Y.; Chang, Z. S.; Tan, J. S.; Wang, X. N.; Zhang, P. F.; Lin, S.; Liu, J. Q.; Li, A. H. Superoxide radical-mediated self-synthesized Au/MoO3- x hybrids with enhanced peroxidase-like activity and photothermal effect for anti-MRSA therapy. ACS Appl. Mater. Interfaces 2022, 14, 13025–13037.
DOI Google Scholar
[268]

Liao, Z. Y.; Xia, Y. M.; Zuo, J. M.; Wang, T.; Hu, D. T.; Li, M. Z.; Shao, N. N.; Chen, D.; Song, K. X.; Yu, X. et al. Metal-organic framework modified MoS2 nanozyme for synergetic combating drug-resistant bacterial infections via photothermal effect and photodynamic modulated peroxidase-mimic activity. Adv. Healthc. Mater. 2022, 11, 2101698.
DOI Google Scholar
[269]

Sun, Y.; Xu, B. L.; Pan, X. T.; Wang, H. Y.; Wu, Q. Y.; Li, S. S.; Jiang, B. Y.; Liu, H. Y. Carbon-based nanozymes: Design, catalytic mechanism, and bioapplication. Coord. Chem. Rev. 2023, 475, 214896.
DOI Google Scholar
[270]

Wang, H.; Li, P. H.; Yu, D. Q.; Zhang, Y.; Wang, Z. Z.; Liu, C. Q.; Qiu, H.; Liu, Z.; Ren, J. S.; Qu, X. G. Unraveling the enzymatic activity of oxygenated carbon nanotubes and their application in the treatment of bacterial infections. Nano Lett. 2018, 18, 3344–3351.
DOI Google Scholar
[271]

Ren, C. X.; Hu, X. G.; Zhou, Q. X. Graphene oxide quantum dots reduce oxidative stress and inhibit neurotoxicity in vitro and in vivo through catalase-like activity and metabolic regulation. Adv. Sci. 2018, 5, 1700595.
DOI Google Scholar
[272]

Yu, M. Z.; Guo, X. Z.; Lu, H. J.; Li, P. L.; Huang, R. B.; Xu, C. N.; Gong, X. D.; Xiao, Y. H.; Xing, X. D. Carbon dots derived from folic acid as an ultra-succinct smart antimicrobial nanosystem for selective killing of S. aureus and biofilm eradication. Carbon 2022, 199, 395–406.
DOI Google Scholar
[273]

Wu, G.; Berka, V.; Derry, P. J.; Mendoza, K.; Kakadiaris, E.; Roy, T.; Kent, T. A.; Tour, J. M.; Tsai, A. L. Critical comparison of the superoxide dismutase-like activity of carbon antioxidant nanozymes by direct superoxide consumption kinetic measurements. ACS Nano 2019, 13, 11203–11213.
DOI Google Scholar
[274]

Wang, X. Y.; Hu, Y. H.; Wei, H. Nanozymes in bionanotechnology: From sensing to therapeutics and beyond. Inorg. Chem. Front. 2016, 3, 41–60.
DOI Google Scholar
[275]

Liang, M. M.; Yan, X. Y. Nanozymes: From new concepts, mechanisms, and standards to applications. Acc. Chem. Res. 2019, 52, 2190–2200.
DOI Google Scholar
[276]

Jiang, B.; Duan, D. M.; Gao, L. Z.; Zhou, M. J.; Fan, K. L.; Tang, Y.; Xi, J. Q.; Bi, Y. H.; Tong, Z.; Gao, G. F. et al. Standardized assays for determining the catalytic activity and kinetics of peroxidase-like nanozymes. Nat. Protoc. 2018, 13, 1506–1520.
DOI Google Scholar
[277]

Li, Y.; Ma, W. S.; Sun, J.; Lin, M.; Niu, Y. S.; Yang, X. C.; Xu, Y. H. Electrochemical generation of Fe3C/N-doped graphitic carbon nanozyme for efficient wound healing in vivo. Carbon 2020, 159, 149–160.
DOI Google Scholar
[278]

Liu, Y. H.; Xu, B. L.; Lu, M. Z.; Li, S. S.; Guo, J.; Chen, F. Z.; Xiong, X. L.; Yin, Z.; Liu, H. Y.; Zhou, D. S. Ultrasmall Fe-doped carbon dots nanozymes for photoenhanced antibacterial therapy and wound healing. Bioact. Mater. 2022, 12, 246–256.
DOI Google Scholar
[279]

Wang, Y. H.; Yao, J. C.; Cao, Z. L.; Fu, P.; Deng, C.; Yan, S. F.; Shi, S.; Zheng, J. P. Peroxidase-mimetic copper-doped carbon-dots for oxidative stress-mediated broad-spectrum and efficient antibacterial activity. Chem. -Eur. J. 2022, 28, e202104174.
DOI Google Scholar
[280]

Liu, M.; Huang, L.; Xu, X. Y.; Wei, X. M.; Yang, X. F.; Li, X. L.; Wang, B. N.; Xu, Y.; Li, L. H.; Yang, Z. M. Copper doped carbon dots for addressing bacterial biofilm formation, wound infection, and tooth staining. ACS Nano 2022, 16, 9479–9497.
DOI Google Scholar
[281]

Wang, X. L.; Lu, Y. G.; Hua, K. W.; Yang, D. Z.; Yang, Y. L. Iodine-doped carbon dots with inherent peroxidase catalytic activity for photocatalytic antibacterial and wound disinfection. Anal. Bioanal. Chem. 2021, 413, 1373–1382.
DOI Google Scholar
[282]

Zou, X. F.; Zhang, L.; Wang, Z. J.; Luo, Y. Mechanisms of the antimicrobial activities of graphene materials. J. Am. Chem. Soc. 2016, 138, 2064–2077.
DOI Google Scholar
[283]

Sun, H. J.; Gao, N.; Dong, K.; Ren, J. S.; Qu, X. G. Graphene quantum dots-band-aids used for wound disinfection. ACS Nano 2014, 8, 6202–6210.
DOI Google Scholar
[284]

Chen, S.; Quan, Y.; Yu, Y. L.; Wang, J. H. Graphene quantum dot/silver nanoparticle hybrids with oxidase activities for antibacterial application. ACS Biomater. Sci. Eng. 2017, 3, 313–321.
DOI Google Scholar
[285]

Tripathi, K. M.; Ahn, H. T.; Chung, M.; Le, X. A.; Saini, D.; Bhati, A.; Sonkar, S. K.; Kim, M. I.; Kim, T. N, S, and P-Co-doped carbon quantum dots: Intrinsic peroxidase activity in a wide pH range and its antibacterial applications. ACS Biomater. Sci. Eng. 2020, 6, 5527–5537.
DOI Google Scholar
[286]
Ge, Y. G.; MacDonald, D. L.; Holroyd, K. J.; Thornsberry, C.; Wexler, H.; Zasloff, M. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 1999 , 43, 782–788.
DOI
[287]

Patch, J. A.; Barron, A. E. Helical peptoid mimics of magainin-2 amide. J. Am. Chem. Soc. 2003, 125, 12092–12093.
DOI Google Scholar
[288]

Tew, G. N.; Scott, R. W.; Klein, M. L.; DeGrado, W. F. De novo design of antimicrobial polymers, foldamers, and small molecules: From discovery to practical applications. Acc. Chem. Res. 2010, 43, 30–39.
DOI Google Scholar
[289]

Liu, D. H.; Choi, S.; Chen, B.; Doerksen, R. J.; Clements, D. J.; Winkler, J. D.; Klein, M. L.; DeGrado, W. F. Nontoxic membrane-active antimicrobial arylamide oligomers. Angew. Chem. 2004, 116, 1178–1182.
DOI Google Scholar
[290]

Thoma, L. M.; Boles, B. R.; Kuroda, K. Cationic methacrylate polymers as topical antimicrobial agents against Staphylococcus aureus nasal colonization. Biomacromolecules 2014, 15, 2933–2943.
DOI Google Scholar
[291]

Cheng, J. C.; Chin, W.; Dong, H. H.; Xu, L.; Zhong, G. S.; Huang, Y.; Li, L. J.; Xu, K. J.; Wu, M.; Hedrick, J. L. et al. Biodegradable antimicrobial polycarbonates with in vivo efficacy against multidrug-resistant MRSA systemic infection. Adv. Healthc. Mater. 2015, 4, 2128–2136.
DOI Google Scholar
[292]

Uppu, D. S. S. M.; Samaddar, S.; Hoque, J.; Konai, M. M.; Krishnamoorthy, P.; Shome, B. R.; Haldar, J. Side chain degradable cationic-amphiphilic polymers with tunable hydrophobicity show in vivo activity. Biomacromolecules 2016, 17, 3094–3102.
DOI Google Scholar
[293]

Konai, M. M.; Haldar, J. Fatty acid comprising lysine conjugates: Anti-MRSA agents that display in vivo efficacy by disrupting biofilms with no resistance development. Bioconjug. Chem. 2017, 28, 1194–1204.
DOI Google Scholar
[294]

Gao, Q.; Yu, M.; Su, Y. J.; Xie, M. H.; Zhao, X.; Li, P.; Ma, P. X. Rationally designed dual functional block copolymers for bottlebrush-like coatings: In vitro and in vivo antimicrobial, antibiofilm, and antifouling properties. Acta Biomater. 2017, 51, 112–124.
DOI Google Scholar
[295]

Immordino, M. L.; Dosio, F.; Cattel, L. Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomedicine 2006, 1, 297–315.
DOI Google Scholar
[296]

Mackay, M. E.; Tuteja, A.; Duxbury, P. M.; Hawker, C. J.; Van Horn, B.; Guan, Z. B.; Chen, G. H.; Krishnan, R. S. General strategies for nanoparticle dispersion. Science 2006, 311, 1740–1743.
DOI Google Scholar
[297]

Noble, G. T.; Stefanick, J. F.; Ashley, J. D.; Kiziltepe, T.; Bilgicer, B. Ligand-targeted liposome design: Challenges and fundamental considerations. Trends Biotechnol. 2014, 32, 32–45.
DOI Google Scholar
[298]

Ishida, T.; Kiwada, H. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. Int. J. Pharm. 2008, 354, 56–62.
DOI Google Scholar
[299]

Li, L. L.; Xu, J. H.; Qi, G. B.; Zhao, X. Z.; Yu, F. Q.; Wang, H. Core–shell supramolecular gelatin nanoparticles for adaptive and “on-demand” antibiotic delivery. ACS Nano 2014, 8, 4975–4983.
DOI Google Scholar
[300]

Kim, J. K.; Uchiyama, S.; Gong, H.; Stream, A.; Zhang, L. F.; Nizet, V. Engineered biomimetic platelet membrane-coated nanoparticles block Staphylococcus aureus cytotoxicity and protect against lethal systemic infection. Engineering 2021, 7, 1149–1156.
DOI Google Scholar
[301]

Wu, S.; Huang, Y.; Yan, J. C.; Li, Y. Z.; Wang, J. F.; Yang, Y. Y.; Yuan, P. Y.; Ding, X. Bacterial outer membrane-coated mesoporous silica nanoparticles for targeted delivery of antibiotic rifampicin against Gram-negative bacterial infection in vivo. Adv. Funct. Mater. 2021, 31, 2103442.
DOI Google Scholar
[302]

Gao, W. W.; Fang, R. H.; Thamphiwatana, S.; Luk, B. T.; Li, J. M.; Angsantikul, P.; Zhang, Q. Z.; Hu, C. M. J.; Zhang, L. F. Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. Nano Lett. 2015, 15, 1403–1409.
DOI Google Scholar
[303]
Tackling drug-resistant infections globally: Final report and recommendations. The review on antimicrobial resistance; chaired by Jim O'Neill; Wellcome Trust and UK Government: London, UK, 2016.
[304]
Harikrishnan, S., Jeemon, P., Mini, G. K., Thankappan, K. R., & Sylaja, P. G. B. D. (2018). GBD 2017 causes of death collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the global burden of disease study 2017. Lancet 2018 , 392, 1736–1788.
[305]

Yahav, D.; Tau, N.; Shepshelovich, D. Assessment of data supporting the efficacy of new antibiotics for treating infections caused by multidrug-resistant bacteria. Clin. Infect. Dis. 2021, 72, 1968–1974.
DOI Google Scholar
[306]

Blair, J. M. A.; Webber, M. A.; Baylay, A. J.; Ogbolu, D. O.; Piddock, L. J. V. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 2015, 13, 42–51.
DOI Google Scholar
[307]

Qadri, H.; Shah, A. H.; Alkhanani, M.; Almilaibary, A.; Mir, M. A. Immunotherapies against human bacterial and fungal infectious diseases: A review. Front. Med. 2023, 10, 1135541.
DOI Google Scholar
[308]

Hamad, M. Antifungal immunotherapy and immunomodulation: A double-hitter approach to deal with invasive fungal infections. Scand. J. Immunol. 2008, 67, 533–543.
DOI Google Scholar
[309]

Din, F. U.; Aman, W.; Ullah, I.; Qureshi, O. S.; Mustapha, O.; Shafique, S.; Zeb, A. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int. J. Nanomedicine 2017, 12, 7291–7309.
DOI Google Scholar
[310]

Zan, G. T.; Wu, Q. S. Biomimetic and bioinspired synthesis of nanomaterials/nanostructures. Adv. Mater. 2016, 28, 2099–2147.
DOI Google Scholar
[311]

Papahadjopoulos, D.; Allen, T. M.; Gabizon, A.; Mayhew, E.; Matthay, K.; Huang, S. K.; Lee, K. D.; Woodle, M. C.; Lasic, D. D.; Redemann, C. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA 1991, 88, 11460–11464.
DOI Google Scholar
[312]

Gubernator, J.; Drulis-Kawa, Z.; Dorotkiewicz-Jach, A.; Doroszkiewicz, W.; Kozubek, A. In vitro antimicrobial activity of liposomes containing ciprofloxacin, meropenem and gentamicin against gram-negative clinical bacterial strains. Lett. Drug Des. Discov. 2007, 4, 297–304.
DOI Google Scholar
[313]

Nicolosi, D.; Scalia, M.; Nicolosi, V. M.; Pignatello, R. Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria. Int. J. Antimicrob. Agents 2010, 35, 553–558.
DOI Google Scholar
[314]

Sachetelli, S.; Khalil, H.; Chen, T.; Beaulac, C.; Sénéchal, S.; Lagacé, J. Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells. Biochim. Biophys. Acta Biomembr. 2000, 1463, 254–266.
DOI Google Scholar
[315]

De Jong, W. H.; Borm, P. J. A. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomedicine 2008, 3, 133–149.
DOI Google Scholar
[316]

Yaraki, M. T.; Zahed Nasab, S.; Zare, I.; Dahri, M.; Moein Sadeghi, M.; Koohi, M.; Tan, Y. N. Biomimetic metallic nanostructures for biomedical applications, catalysis, and beyond. Ind. Eng. Chem. Res. 2022, 61, 7547–7593.
DOI Google Scholar
[317]

Niidome, T.; Yamagata, M.; Okamoto, Y.; Akiyama, Y.; Takahashi, H.; Kawano, T.; Katayama, Y.; Niidome, Y. PEG-modified gold nanorods with a stealth character for in vivo applications. J. Control. Release 2006, 114, 343–347.
DOI Google Scholar
[318]

Wang, X. Y.; Wang, H.; Zhou, S. Q. Progress and perspective on carbon-based nanozymes for peroxidase-like applications. J. Phys. Chem. Lett. 2021, 12, 11751–11760.
DOI Google Scholar
[319]

Singh, R.; Umapathi, A.; Patel, G.; Patra, C.; Malik, U.; Bhargava, S. K.; Daima, H. K. Nanozyme-based pollutant sensing and environmental treatment: Trends, challenges, and perspectives. Sci. Total Environ. 2023, 854, 158771.
DOI Google Scholar
[320]

Shan, X. T.; Gong, X.; Li, J.; Wen, J. Y.; Li, Y. P.; Zhang, Z. W. Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharm. Sin. B 2022, 12, 3028–3048.
DOI Google Scholar
[321]

Liu, C.; Luo, L. J.; Zeng, L. Y.; Xing, J.; Xia, Y. Z.; Sun, S.; Zhang, L. Y.; Yu, Z.; Yao, J. L.; Yu, Z. S. et al. Porous gold nanoshells on functional NH2-MOFs: Facile synthesis and designable platforms for cancer multiple therapy. Small 2018, 14, 1801851.
DOI Google Scholar
[322]

Zhang, K.; Loong, S. L. E.; Connor, S.; Yu, S. W. K.; Tan, S. Y.; Ng, R. T. H.; Lee, K. M.; Canham, L.; Chow, P. K. H. Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic carcinoma xenografts in nude mice. Clin. Cancer Res. 2005, 11, 7532–7537.
DOI Google Scholar
[323]

Bonvalot, S.; Rutkowski, P. L.; Thariat, J.; Carrère, S.; Ducassou, A.; Sunyach, M. P.; Agoston, P.; Hong, A.; Mervoyer, A.; Rastrelli, M. et al. NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc): A multicentre, phase 2-3, randomised, controlled trial. Lancet Oncol. 2019, 20, 1148–1159.
DOI Google Scholar
[324]

Hu, J.; Tang, F.; Wang, L. H.; Tang, M.; Jiang, Y. Z.; Liu, C. Nanozyme sensor based-on platinum-decorated polymer nanosphere for rapid and sensitive detection of Salmonella typhimurium with the naked eye. Sens. Actuators B: Chem. 2021, 346, 130560.
DOI Google Scholar
[325]

Li, J. N.; Liu, W. Q.; Wu, X. C.; Gao, X. F. Mechanism of pH-switchable peroxidase and catalase-like activities of gold, silver, platinum and palladium. Biomaterials 2015, 48, 37–44.
DOI Google Scholar
[326]
Liu, Y. F.; Zhang, Y. H.; Liu, Q. Y.; Wang, Q.; Lin, A. Q.; Luo, J.; Du, Y.; Lin, Y. W.; Wei, H. In vitro measurement of superoxide dismutase-like nanozyme activity: A comparative study. Analyst 2021 , 146, 1872–1879.
DOI
[327]

Jin, J.; Li, L. L.; Zhang, L. H.; Luan, Z. H.; Xin, S. Q.; Song, K. Progress in the application of carbon dots-based nanozymes. Front. Chem. 2021, 9, 748044.
DOI Google Scholar
[328]

Deng, S. Q.; Tu, Y. W.; Fu, L.; Liu, J.; Jia, L. A label-free biosensor for selective detection of Gram-negative bacteria based on the oxidase-like activity of cupric oxide nanoparticles. Microchim. Acta 2022, 189, 471.
DOI Google Scholar
[329]

Hao, C. L.; Qu, A. H.; Xu, L. G.; Sun, M. Z.; Zhang, H. Y.; Xu, C. L.; Kuang, H. Chiral molecule-mediated porous Cu x O nanoparticle clusters with antioxidation activity for ameliorating Parkinson’s disease. J. Am. Chem. Soc. 2019, 141, 1091–1099.
DOI Google Scholar
[330]

Liu, T. F.; Xiao, B. W.; Xiang, F.; Tan, J. L.; Chen, Z.; Zhang, X. R.; Wu, C. Z.; Mao, Z. W.; Luo, G. X.; Chen, X. Y. et al. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases. Nat. Commun. 2020, 11, 2788.
DOI Google Scholar
[331]

Waldmeier, P.; Sigel, H. Metal ions and hydrogen peroxide. XXVI. Kinetics and mechanism of the catalase-like activity of cobalt(III) hematoporphyrin. Inorg. Chem. 1972, 11, 2174–2180.
DOI Google Scholar
[332]

Waldmeier, P.; Sigel, H. Inhibition of the catalase-like activity of cobalt(III)-hematoporphyrin by amino acids, adenine and related ligands stability of the inhibitor adducts. J. Inorg. Nucl. Chem. 1973, 35, 1741–1748.
DOI Google Scholar
[333]

Bellot, F.; Hardré, R.; Pelosi, G.; Thérisod, M.; Policar, C. Superoxide dismutase-like activity of cobalt(II) complexes based on a sugar platform. Chem. Commun. 2005, 5414–5416
DOI Google Scholar
[334]

Gao, L. Z.; Fan, K. L.; Yan, X. Y. Iron oxide nanozyme: A multifunctional enzyme mimetic for biomedical applications. Theranostics 2017, 7, 3207–3227.
DOI Google Scholar
[335]

Li, S. J.; Pang, E. N.; Gao, C.; Chang, Q.; Hu, S. L.; Li, N. Cerium-mediated photooxidation for tuning pH-dependent oxidase-like activity. Chem. Eng. J. 2020, 397, 125471.
DOI Google Scholar
[336]

Romero, I.; Dubois, L.; Collomb, M. N.; Deronzier, A.; Latour, J. M.; Pécaut, J. A dinuclear manganese(II) complex with the {Mn2(μ-O2CCH3)3}+ core: Synthesis, structure, characterization, electroinduced transformation, and catalase-like activity. Inorg. Chem. 2002, 41, 1795–1806.
DOI Google Scholar
[337]

Kaizer, J.; Kripli, B.; Speier, G.; Párkányi, L. Synthesis, structure, and catalase-like activity of a novel manganese(II) complex: Dichloro[1,3-bis(2′-benzimidazolylimino)isoindoline]manganese(II). Polyhedron 2009, 28, 933–936.
DOI Google Scholar
[338]

Liao, Z. R.; Zheng, X. F.; Luo, B. S.; Shen, L. R.; Li, D. F.; Liu, H. L.; Zhao, W. Synthesis, characterization and SOD-like activities of manganese-containing complexes with N,N,N′, N′-tetrakis(2′-benzimidazolyl methyl)-1,2-ethanediamine (EDTB). Polyhedron 2001, 20, 2813–2821.
DOI Google Scholar
[339]

DeFreitas-Silva, G.; Rebouças, J. S.; Spasojević, I.; Benov, L.; Idemori, Y. M.; Batinić-Haberle, I. SOD-like activity of Mn(II) β-octabromo- meso-tetrakis( N-methylpyridinium-3-yl)porphyrin equals that of the enzyme itself. Arch. Biochem. Biophys. 2008, 477, 105–112.
DOI Google Scholar
[340]

Ragg, R.; Natalio, F.; Tahir, M. N.; Janssen, H.; Kashyap, A.; Strand, D.; Strand, S.; Tremel, W. Molybdenum trioxide nanoparticles with intrinsic sulfite oxidase activity. ACS Nano 2014, 8, 5182–5189.
DOI Google Scholar
[341]

Niculescu, A. G.; Grumezescu, A. M. Polymer-based nanosystems—A versatile delivery approach. Materials 2021, 14, 6812.
DOI Google Scholar
[342]

Chen, T. M.; Zou, H.; Wu, X. J.; Liu, C. C.; Situ, B.; Zheng, L.; Yang, G. W. Nanozymatic antioxidant system based on MoS2 nanosheets. ACS Appl. Mater. Interfaces 2018, 10, 12453–12462.
DOI Google Scholar
Publication history
Copyright
Acknowledgements

Publication history

Received: 15 July 2023
Revised: 18 October 2023
Accepted: 23 October 2023
Published: 07 December 2023
Issue date: February 2024

Copyright

© Tsinghua University Press 2023

Acknowledgements

Acknowledgements

This work was supported by the Department of Defense, Office of Naval Research (ONR award N00014-20-1-2418); National Institutes of Health, National Institute on Deafness and Other Communication Disorders (NIHDC016644).

Return